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Trichomonas vaginalis is a parasitic protozoan responsible for 170 million new 
infections each year and is the most prevalent non-viral sexually transmitted infection 
worldwide according to The World Health Organisation. Research on the parasites 
pathogenicity and lifestyle has been limited until the publishing of the parasites’ 
genome in 2007 and an emergence of studies documenting links between T. vaginalis 
infection and a number of adverse health outcomes, including an increased risk of HIV 
acquisition and cervical cancer. Research into DNA repair pathways within this 
organism have also been limited. In this research I describe two DNA 3-methyl adenine 
glycosylase homologues (TvAAG1 and TvAAG2) characterised via biochemical 
methods. In addition to the creation of an atlas of DNA repair proteins and enzymes 
present in T. vaginalis, and a close evolutionary relative, Tritrichomonas foetus via 
bioinformatical analysis. Biochemical analysis of TvAAG1 reveals it as the first 
bifunctional AAG type enzyme to be described. Bioinformatic analysis suggests 
TvAAG1 and TvAAG2 are most likely the result of horizontal gene transfer between 
an ancestor of both T. vaginalis and T. foetus and a donor belonging to the Bacteroidetes 
phylum. The DNA repair pathways of both parasites are reduced compared to humans. 
The parasites have the main components for base excision repair, mismatch repair and 
homologous recombination repair but not non-homologous end joining.  In light of 
reports of antibiotic resistance further research should be done on the parasites DNA 
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1.1 DNA Repair  
 
Deoxyribonucleic acid (DNA) is the molecular carrier of genetic information in cellular 
organisms. The faithful replication and translation of the double helix structure, 
famously described by Watson and Crick in 1953, is a fundamental requirement in all 
organisms to ensure integrity of the genome. DNA consists of two polynucleotide 
strands linked together by hydrogen bonding between the bases of the nucleotides. 
Nucleotide monomers are made up of; one of four nitrogenous bases, a deoxyribose 
sugar, and a phosphate molecule. There are four types of bases; adenine, guanine, 
cytosine and thymine. Each one has a different chemical structure which allows them 
to be read by DNA processing enzymes. Despite DNA being a stable molecule, its bases 
are highly reactive (Lindahl, 1993). Spontaneous chemical reactions between the bases 
and other molecules within the cell can lead to base modifications, formation of abasic 
sites (AP sites) and single strand or double strand breaks. All of which can lead to 
mutations if not repaired and can be cytotoxic. These chemical alterations to the DNA 




Up to 70,000 genomic lesions are formed in human cells per day (Lindahl and 
Barnes, 2000) due to constant attack by endogenous chemical reactions and exogenous 
DNA damaging agents. This means an efficient and effective DNA repair mechanism 
is essential in all organisms to prevent the effects of DNA damage and an increased 
mutational load. The variety of different DNA repair mechanisms that can combat these 
lesions and other types of DNA damage are collectively known as the DNA damage 
response (DDR) (and Elledge, 2007).  The importance of DDR is highlighted by the 
evolutionary conservation of DNA repair. Defective repair systems can cause genomic 
instability leading to mutations and cell death or disease. Genomic instability is an 
enabling characteristic of the eight hallmarks of cancer (Hanahan and Weinberg, 2011) 
and mutations in specific DNA repair genes have been linked to an increased risk for 
several types of cancer; breast cancer predisposition gene 1 and 2 (BRCA1/BRCA2) 
mutations are associated with breast, ovarian and prostate cancer (Mavaddat et al., 
2013; Pilié et al., 2017) adenine DNA glycosylase (MYH) mutations are linked to 
colorectal adenomas (Sieber et al., 2003) and ERCC2 mutations are associated with 
bladder cancer (Kim et al., 2016). This highlights the importance of the DDR system in 
respect to human disease as it has also been linked to Alzheimer’s and ageing (Yu, 








1.1.1. Types of DNA Damage 
 
DNA is subjected to various types of damage within the cell.  Damage that occurs within 
the cell is known as endogenous DNA damage and includes base deamination, oxidative 
damage, depurination and methylation. Endogenous damage occurs when DNA reacts 
with naturally occurring molecules within the cell, such as water and reactive oxygen 
species (ROS), resulting in spontaneous DNA lesions. DNA is also damaged by 
environmental agents, such as radiation and alkylating agents, which is termed 
exogenous DNA damage.  
 
1.1.1.1 Endogenous DNA Damage 
 
Base deamination is a major source of endogenous damage to DNA. Within the 
cell, naturally present H2O molecules participate in spontaneous hydrolysis reactions 
with DNA bases which results in a loss of their exocyclic amine (NH2) (Lindahl, 1993). 
Adenine, guanine, cytosine and 5-methyl cytosine bases can be deaminated. Their 
deamination products are hypoxanthine (Hx), xanthine, uracil and thymine respectively 
(Figure 1.1). When bound to a deoxyribose sugar deoxyadenosine is deaminated to 
deoxyinosine (Hx is the corresponding base). Deoxyinosine formation leads to 
transition mutations as it is incorrectly read by DNA replicative machinery as 
deoxygaunosine due to its structure. This leads to the insertion of deoxycytidine in place 
of deoxythymidine (Yasui et al., 2008). Cytosine and 5-methyl cytosine (5meC) show 
the highest rates of deamination, with 5meC being more frequently deaminated than 
cytosine (Lindahl, 1979). Deamination of both cytosine and 5meC is repaired via the 
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base excision repair pathway (BER). Deamination of 5meC leads to G:T mismatches 
which are efficiently excised via BER with thymine DNA glycosylase (TDG). 
Deamination of cytosine causes the formation of uracil and leads to GC àTA mutations 




























Figure 1.1: The Deamination of Bases with Exocyclic Amines via Hydrolysis.  
Hydrolysis reactions within the cell result in the loss of the exocyclic amine (NH2) group from the 
base. Adenine is deaminated to hypoxanthine, guanine is deaminated to xanthine, cytosine is 
deaminated to uracil and 5-methyl cytosine is deaminated to thymine.   
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 Oxidative damage via endogenous attack by reactive oxygen species (ROS) 
causes a variety of DNA damage. ROS are highly electrophilic, and the most reactive 
species is the hydroxyl radical (•OH) (Tropp, 2011). Hydroxyl radicals react with DNA 
by attacking the sugar residue leading to single stranded DNA breaks (Giloni et al., 
1981), removing hydrogen atoms from methyl groups and by adding to their double 
bonds both of which cause oxidised base damage.  
 
ROS are normally produced within the mitochondria as a by-product of cellular 
respiration and peroxisomal metabolism (Henle and Linn, 1997). They are essential as 
cellular messengers in redox signalling and in signalling defence responses against 
pathogens (Errol C. Friedberg, 2005; Segal, 2005) However, excess ROS levels have 
been linked to diseases including cancer (Liou and Storz, 2010) and Alzheimer’s 
(Mohsenzadegan and Mirshafiey 2012) and can cause over 100 different types of 
oxidative base lesions. The saturated imidazole ring 8-oxoguanine (8oxoG) is one of 
the most frequent lesions formed by oxidative damage (Ames, 1989). The guanine base 
is the most readily oxidised of all the DNA bases. 8oxoG incorrectly pairs with adenine 
in place of cytosine leading to mutations (Figure 2).  
 
Figure 1.2: Correct and Mismatch Pairing of Guanine and 8oxoG.  
a) guanine and cytosine b) 8oxoG and adenine mismatch.  8oxoG – 8-oxoguanine.  
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Another source of DNA damage is depurination via hydrolysis. Depurination 
causes the formation of AP sites and single strand breaks within the DNA. The 
generation of AP sites is an important step during the BER pathway (Lindahl and 
Barnes, 2000) but can be spontaneously produced when the N-glycosyl bond linking 
the nitrogenous base and phosphate groups of the DNA monomer is hydrolysed. 
Spontaneous generation of AP sites is affected by extreme pH and temperature 
conditions within the cell and around 10,000 AP sites are created per day within 
human cells (Lindahl, 1993) These AP sites can readily convert into single strand 
breaks due to AP sites being inherently unstable.   
 
Epigenetic modification refers to the heritable modification of the genome 
outside of changes to the DNA sequence. DNA methylation is a post-replication 
modification involved in regulation of gene expression which involves the use of DNA 
methyltransferases (DNMTs) and S-adenosylmethionine (SAM) as a methyl donor 
(Moore, Le and Fan, 2012). Outside of normal epigenetic modification SAM acts as a 
source of endogenous damage as it can spontaneously produce over 4000 lesions per 
cell per day in mammals (Rydberg and Lindahl 1982). The lesions produced by SAM 
in Rydberg and Lindahl’s experiment included 7-methylguanine (7meG), 3-
methyladenine (3meA) and O6-methylguanine.  
 
The formation of 7meG and 3meA by abnormal methylation is cytotoxic as 
these DNA adducts block replication or form mutagenic AP sites if not repaired. 
Destabilization of the glycosyl bond on 7meG can generate imidazole ring opening 
which blocks replication (Barbarella et al., 1991). 7meG accounts for around 75% of 
methylated lesions in DNA (Beranek, 1990). 3meA is cytotoxic due to its interference 
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with polymerases and the DNA minor groove during replication (Larson et al., 1985). 
 
Endogenous alkylation can also form the highly mutagenic O6-methylguanine 
O4-methylthymine, O4-ethylthymine lesions which cause GC à AT and TA à CG 
transition mutations if replicated before repair (Warren, Forsberg and Beese, 2006). 
Table 1.1 lists the all possible positions of base modifications caused by alkylating 
agents. Alkylated lesions can also be formed by the effects of exogenous agents, as 
discussed in section 1.1.1.2.  
 
 
Table 1.1: Possible Positions of Base Modifications Caused by Alkylating Agents. Exocyclic 
positions on DNA bases italicized superscripts. (Singer and Kusmierek, 1982; Singer, 1986; Errol 













Modified base  Position  
Adenine  N1, N3, N6, N7  
Cytosine  N3, N4, and O2  
Guanine  N1, N2, N3, N7, and O6   
Thymine  N3, O2, and O4  
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Table 1.2: Biologically Significant Lesions Produced via Exogenous and Endogenous DNA 
Damage and the DNA Repair Mechanisms that Recognise the Lesions. BER- base excision 
repair, DSB- double strand break, DSBR- double strand break repair, MGMT – O6-methylguanine 
DNA methyltransferase, MMR- mismatch repair, SSB- single strand break, SSBR – single strand 
break repair.  
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MMR or direct reversal of damage via 












UV radiation Pyrimidine dimers NER 
Oxidised purines and pyrimidines BER 
 
Single strand breaks SSBR 
Double strand breaks 
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MMR or direct reversal of damage via 
methyltransferases e.g  
BER 
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1.1.1.2 Exogenous DNA Damage 
 
Exogenous damage occurs when substances and chemical agents from outside the cell 
damage the DNA directly or indirectly. The main sources of endogenous damage are 
radiation sources and alkylating agents. 
 
Ionizing radiation includes, alpha, beta and gamma radiation, neutrons and X-
rays. It is produced from many sources within the environment including; X-rays from 
medical devices, cosmic radiation and soil and rocks (World Health Organisation, 
2016). Ionising radiation can cause direct and indirect DNA damage. Direct damage 
produces oxidised bases or single strand breaks (SSB) with unique 3’-phosphoglycolate 
modified ends (Henner et al., 1982; Obe et al., 1992). Indirect damage via ionising 
radiation involves generation of hydroxyl radicals via radiolysis of water within the cell 
(Friedberg, 2005) Damage via hydroxyl radicals accounts for 65% of DNA damage 
caused by ionising radiation (Vignard et al., 2013) Ionising radiation also causes toxic 
double strand breaks through oxidation of base and sugar residues closely located on 
opposite strands of the double helix (Hutchinson, 1985; Iliakis, 1991) 
 
Ultraviolet radiation (UV) is another significant source of DNA damage, this 
type of radiation is emitted from the sun and is the major cause of skin cancer in humans 
(Davies, 1995; Kiefer 2007) UV radiation can be categorized into three groups based 
on its wavelength (Table 1.3).  DNA absorbs the maximum amount of UV radiation at 
260 nm and then absorption drops. UV-C is the most dangerous as its wavelength range 
includes the maximum absorbance for DNA. Sunlight is composed of a small 
percentage of UV-A and UV-B, visible light and infrared. The UV-C is filtered out by 
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atmospheric oxygen (Yu and Lee, 2017). UV-C and UV-B damage DNA by creating 
covalent linkages between two pyrimidines leading to the production of cyclobutane 
pyrimidine dimers and pyrimidine (6-4) pyrimidinone photoproducts (Varghese, 1972; 
Mitchell and Nairn, 1989; Davies, 1995) These two photoproducts are bulky dimers 
which distort the DNA helix leading to cytotoxicity if not repaired by nucleotide 
excision repair (NER) (Yu and Lee, 2017). Other photoproducts generated include; 
pyrimidine hydrate, thymine glycols and dipurine adducts (Demple and Linn, 1982; 
Bose et al., 1983; Kumar et al., 1991; Mitchell et al., 1991). UV-B radiation also causes 
the formation of pyrimidine dimers but at less frequency than UV-C (You et al., 2000; 
Errol C. Friedberg, 2005; Rastogi et al., 2010). UV-A radiation causes the formation of 
8-oxoG lesions and cyclobutane pyrimidine dimers (Epe, 1991; Rochette et al., 

















DNA alkylation, including endogenous methylation as previously discussed, 
can also be caused by exogenous alkylating agents to form DNA lesions. Alkylating 
agents are commonly used as chemotherapeutic agents, such as temozolomide (TMZ) 
and cyclophosphamide (Kondo et al., 2010). Tobacco smoke contains 
nitrosaminoketone which reacts with DNA to produce O6-methylguanine (Goodsell, 
2004). Alkylating agents are electrophilic with high affinity for base ring nitrogen and 
oxygen atoms forming DNA adducts (Table 1.2) which are removed by direct 
demethylation, BER and mismatch repair (MMR). Urethane and vinyl chloride 
exposure causes 1,N6-ethenoadenosine (εA) production. eA is a bulky alkylation adduct 
which is highly mutagenic (Pandya and Moriya, 1996). 
 
1.1.2. Base Excision Repair 
 
Base excision repair (BER) is one of many DNA repair pathways which make up the 
DDR. The general features of the base excision repair pathway were first outlined by 
Thomas Lindahl in 1973 with his discovery of the Escherichia coli (E. coli) uracil-DNA 
glycosylase. The general mechanism of BER involves initiation by a DNA glycosylase 
which removes the damaged base leaving an AP site. The AP site is removed by an AP 
lyase or AP endonuclease and downstream proteins, including DNA polymerases and 
DNA ligases, work to ensure the DNA is repaired.  
 
DNA glycosylases can be monofunctional or bifunctional. Monofunctional 
glycosylases have intrinsic DNA glycosylase activity whereas bifunctional 
glycosylases have glycosylase and additional AP lyase activity. Monofunctional 
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glycosylases, such as N-methylpurine DNA glycosylase (MPG) or UDG, initiate BER 
after recognition of a specific lesion whilst scanning duplex DNA. The glycosylase 
‘pinches’ the DNA whilst scanning causing helix distortion and allowing the damaged 
base to be flipped out of the major groove into a substrate binding pocket to form a 
protein-substrate complex (Huffman et al., 2005). Within the substrate binding pocket 
an activated water molecule is used to hydrolyse the N-glycosidic bond between the 
base and deoxyribose molecule which generates an AP site (Schermerhorn and Delaney, 
2014). AP sites are removed by an AP endonuclease, APE1 in mammalian cells 
(Demple, Herman and Chen, 1991), which cleaves the DNA backbone 5’ to the AP site 
which generates a strand break with a 3’hydroxyl (3’OH) and 5’deoxyribosephosphate 
(dRP) ends.   
 
Bifunctional glycosylases, such as 8-Oxoguanine DNA Glycosylase (OGG1), 
use an amine nucleophile to catalyse the glycosidic bond and DNA backbone cleavage. 
Bifunctional glycosylases have intrinsic b-lyase or b/d-lyase activity which cleaves 
DNA backbone 3’ to the AP site. b-elimination proceeds via formation of a Schiff base, 
a covalent protein DNA intermediate, to generate a single strand break with 3’phospho 
a,b-unsaturated aldehyde (PUA) and 5’phosphate (5’P) termini (Schermerhorn and 
Delaney, 2014). Schiff base intermediates bases can be detected by reduction with 
borohydride to forms a covalent DNA-glycosylase adduct that’s detectable in SDS 
PAGE experiments. If the bifunctional glycosylase has b/d-lyase activity the DNA 
backbone is cleaved in two steps, b-elimination followed by d-elimination to generate 
3’-phosphate (3’P) (Wiederhold et al., 2004). 
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The non-conventional termini of the single strand breaks generated by AP 
endonuclease or AP lyase block DNA polymerase extension and DNA ligase nick 
ligation which require conventional 3’OH and 5’P ends (Wilson, 2007). These non-
conventional blocking residues, 5’dRP, 3’PUA and 3’P, need to be removed by end-
processing enzymes before DNA repair can be completed. DNA polymerase-b has 
intrinsic dRP excision activity in addition to its polymerase activity which allows it to 
remove the 5’dRP ends left by APE1 and generate the 5’P required for ligation (Prasad 
et al., 1998). DNA polymerase l and DNA polymerase i can also clean up dRP residues 
(Bebenek, 2001; Garcı́a-Dı́az et al., 2001).  3’PUA and 3’P ends can be cleaned up by 
APE1 to leave conventional 3’OH ends. Polynucleotide kinase (PNK) is the primary 
enzyme that removes 3’P blocking termini (Jilani et al., 1999).  
 
After the action of end processing enzymes to generate conventional 3’OH and 
5’P ends Polb inserts a single nucleotide at the 3’OH end of the nick, followed by nick 
sealing by a DNA ligase which generates a covalent phosphodiester bond to join the 
upstream 3’OH end and downstream 5’P ends. This pathway of processing the AP site, 
via removing blocking termini and the insertion of a single nucleotide, is known as the 
short patch base excision repair pathway (SP-BER). DNA ligase IIIa is the DNA ligase 
associated with SP-BER, it acts in a complex with scaffold protein X-ray cross-
complementing protein 1 (XRCC1) (Cappelli et al., 1997).  
 
If 5’ blocking residues are not removed BER proceeds down the long patch 
repair pathway (LP-BER) to process the AP site.  In LP-BER the AP site is removed by 
an AP endonuclease leaving a conventional 3’OH terminus at the 5’ side to the nick and 
a 5’dRP blocking terminus at the 3’ side to the nick. DNA polymerase d or DNA 
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polymerase e bind to the 3’OH substrate and insert up to 12 bases, which includes the 
removed base plus several bases downstream. This strand displaces the strand at the 3’ 
side of the nick containing the 5’dRP terminus to generate a flap intermediate. The 
displaced strand is removed by flap endonuclease 1 (FEN1) and LigI, the DNA ligase 
associated with LP-BER (Tomkinson et al., 2006), seals the nick between the 3’OH and 
5’P ends. The accessory protein proliferating cell nuclear antigen (PCNA) facilitates 
DNA synthesis with Pold and Pole by binding to FEN1 (Gary et al., 1999).  
 
1.1.3. Glycosylases and DNA 3-methyladenine Glycosylase 
 
DNA glycosylases are an essential component of the base excision repair pathway. This 
is highlighted by the fact they are evolutionary conserved throughout the kingdom of 
life. DNA glycosylases can be found in eukaryotes (Homo sapiens (H. sapiens) AAG, 
Saccharomyces cerevisiae (S. cerevisiae) DNA-3-methyladenine glycosylase (MAG)), 
prokaryotes (E. coli alkyladenine-DNA glycosylase (AlkA)), and archaea 
(Methanococcus jannaschii 8-Oxoguanine DNA glycosylase II (OGG2)). Glycosylases 
are diverse and can excise a wide variety of DNA lesions.  
 
Glycosylases can be sub-classified into six super families based on their 
structures. The four super families found within mammalian species include; the helix-
hairpin-helix (HhH) glycosylases, the uracil glycosylases, the endonuclease VIII-like 
glycosylases and the 3-methylpurine glycosylases (Jacobs and Schär, 2011). The 
remaining two super families are found within bacterial and archaic genomes; helix-
two turn-helix glycosylases (H2TH) and the alkylpurine DNA glycosylases (ALKs) 
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(Brooks et al., 2013) All classes of glycosylases have evolved a base-flipping 
mechanism of recognition except from the ALKs (Brooks et al 2013). 
 
The HhH super family, also known as endonuclease III Nth-like superfamily, 
consists of glycosylases which share a HhH motif and catalytic aspartate residue and 
have similar 3-dimensional structures. The prototype for this family is E. coli 
endonuclease III (Nth) of which the crystal structure was used to identify the 
characteristic features of the HhH superfamily (Thayer et al., 1995). Most endonuclease 
III homologs also have an iron-sulfur cluster loop (FCL). The HhH super family can be 
further divided into six distinct families based on phylogenetic analysis of 234 HhH 
glycosylases from 94 genomes by Denver, Swenson and Lynch (2003), which named 
the families based on functionally characterised glycosylases which were included in 
the specific group. These six sub-families include Nth, OggI, A/G-mismatch-specific 
adenine glycosylase (MutY/Mig), AlkA, N-methylpurine-DNA glycosylase II (MpgII) 
and OggII. An additional archaeal sub-family was identified in 2005 by Lingaraju et al. 
through the crystallisation of Pyrobaculum aerophilum GO-glycosylase (AGOG 
)which contains the HhH motif, founding the AGOG family. Analysis of the crystal 
structure of E. coli TAG showed it to be an additional member of the HhH super family 
(Drohat et al., 2002).  
 
The UDG super family consists of monofunctional glycosylases which remove 
uracil from DNA. The superfamily can be subdivided into six subfamilies based on 
characteristic motifs. Families I-III are found within eukaryotes; Family I/UDGs, 
family II/MUGs, family III/SMUGs. Families IV, V and VI are found in thermophilic 
 29 
and hyper thermophilic bacteria and archaea (Schormann, Ricciardi and 
Chattopadhyay, 2014).   
 
The endonuclease VII-like glycosylase superfamily also known as the Fpg/Nei 
superfamily includes bifunctional glycosylases which share a highly conserved C-
terminus containing a helix-two-turn helix motif and a conserved zinc-finger motif 
(Boiteux, Coste and Castaing, 2017). This group includes E. coli formamidopyrimidine-
DNA glycosylase (Fpg) (Boiteux, O'Connor and Laval, 1987), E. coli endonuclease 
VIII (Nei) (Saito et al., 1997), and mammalian homologs Nei-like (NEIL) NEIL1 
(Hazra et al., 2002a) and NEIL2 (Hazra et al., 2002b).  
 
The fourth super family of glycosylases found in mammalian cells is the N-
methylpurine DNA glycosylases that do not contain HhH motifs and so form a separate 
structural class of N-methylpurine glycosylases. Human MPG also known as DNA 3-
methyladenine glycosylase (AAG) repairs alkylation and oxidative damage by excising 
a wide range of lesions including; 3meA, 7meG, eA and Hx (Engelward et al., 1997). 
The glycosylases in this super family share similarity with the protein core or active site 
of human AAG. The structure of AAG consists of a single domain of mixed a/b helices 
and strands.  The first MPG was originally identified in rat hepatoma cells (O'Connor 
and Laval, 1990) and other glycosylases within this class can be found in; mouse, 
Arabidopsis thaliana (Santerre and Britt, 1994), Bacillus subtilis (Morohoshi et al., 
1993), Borrelia burgdorferi (Fraser et al., 1997), Mycobacterium tuberculosis (Cole et 
al., 1998) and humans. AAG is the only enzyme to be identified in humans that repairs 
alkylation damage. Work by O’Brien and Ellenberger (2003) suggests that human AAG 
is predominantly a hypoxanthine DNA glycosylase due to the large difference in rate 
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enhancement for substrate excision between Hx and alkylated purines.  Like most other 
class of glycosylase AAG utilizes a base flipping mechanism to flip the base into the 
enzyme active site. Lau and Scharer et al (1998) used the crystal structure of human 
AAG in complex to DNA, containing a pyrrolidine abasic nucleotide (pyr), to 
investigate how AAG was able to recognise and excise so many substrates that are not 
structurally similar and do not all distort the DNA helix. Their work revealed that AAG 
binds to the DNA minor groove and flips out the base into its substrate binding pocket. 
AAG has a mixed a/b structure with a protruding b hairpin which inserts into the minor 
groove and displaces the nucleotide for excision. A Tyrosine (Tyr)-162 residue inserts 
into the space left by the flipped-out base and the DNA is bent by about 22° at this site. 
The pyr is held in the substrate binding pocket, next to the enzymes active site, by 
protein contact with flanking AAG surface phosphates. In the pocket the base stacks 
between aromatic side chains Tyr-127, His-136 and Tyr 159. A water molecule within 
the active site then displaces the glycosidic bond between the base and deoxyribose 
sugar. Further studies with AAG in complex with DNA containing eA confirm the base 
flipping mechanism for base excision by AAG is similar for different substrates. Base 
excision of both pyr and eA involve the same conformation of AAG, a similar bent 
angle of DNA at Tyr 162 and similar binding of the substrates within the substrate 
binding pocket including the side chain orientation where the base is stacked (Lau et 
al., 2000). 
 
An additional fifth glycosylase superfamily has recently been described. The 
ALKs were first identified as a glycosylase superfamily after the purification of AlkC 
and AlkD from Bacillus cereus (Dalhus et al., 2007). The two alkylpurine glycosylases 
repair alkylation damage and are specific for 3meA and 7meG DNA adducts (Alseth et 
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al., 2006), ALK glycosylases contain characteristic HEAT repeats, a motif consisting 
of two alpha helices linked by a short loop (Brooks et al., 2013).   
 
1.2. The Protozoan Parasite Trichomonas vaginalis  
 
Trichomonas vaginalis (T. vaginalis) is an early diverging eukaryotic protozoan which 
belongs to the Parabasalia class of the Excavata supergroup (Adl et al., 2012). The 
classification of T. vagianlis is shown in Figure1.3. T. vaginalis is the causative agent 
of the sexually transmitted infection trichomoniasis. Trichomoniasis was long regarded 
as a ‘self-clearing nuisance’ and there was little research regarding its pathogenicity and 
virulence or control efforts despite it being the most commonly transmitted, non-viral 
sexual infection worldwide according to the World Health Organisation (WHO, 2012). 
The Centres for Disease Control and Prevention (CDC, 2018) have marked 
trichomoniasis as one of five neglected parasitic diseases prioritised for public health 
action. Studies associating T. vaginalis infection with an increased risk of HIV 
acquisition (Kissinger and Adamski, 2013) cervical cancer (Tao et al., 2014; Yang et 
al., 2018), in addition to reports of antibiotic resistance (Schwebke and Barrientes, 
2006; Upcroft et al., 2009) have led to an increased importance of research into this 
parasite.  
 
Tritrichomonas foetus (T. foetus) is an evolutionary relative to T. vaginalis 
belonging to the Tritrichomonadida order of the Parabasalia class (Figure 1.3). It infects 
the reproductive system of cattle causing bovine trichomoniasis (Rae et al., 2004; 
Mardones et al., 2008) and the intestinal tract of cats (Levy et al., 2003; Gunn-Moore 
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et al., 2007; Lim et al., 2010). Bovine trichomoniasis is of global importance due to its 










Figure1.3 Classification of Trichomonads. Classification of Trichomonads including 


















The World Health Organisation survey data from 2008 estimated a total of 276.4 million 
new cases of T. vaginalis infection in humans between the age of 15-49 years, making 
it the most common STI worldwide, with more than 100 million more new cases 
compared to Chlamydia trachomatis infection which was recorded at 105.7 million new 
cases. Global distribution of T. vaginalis cases is listed in Table 1.4.  
Table 1.4: Incidence and Prevalence Data for T. vaginalis Cases by Region in Adults Between 
15 and 49 Years of Age. Data from The World Health Organisation Global incidence and 
prevalence of selected curable sexually transmitted infections 2008 report (accessed at: 
https://www.who.int/reproductivehealth/publications/rtis/stisestimates/en/ ) 
 
Humans are the only natural host of T. vaginalis. The parasite infects the 
squamous epithelium of the lower urogenital tract of women (vulva, vagina and urethra) 
and men (urethra) after transmission via sexual contact. Common symptoms of 
trichomoniasis, as listed on the CDC website, include; irritation, redness and soreness 
of genitals, unusual vaginal discharge, irritation and discharge from the penis and 
dysuria. Vaginal discharge is a clinical symptom of trichomoniasis described as frothy 
Region Incidence (million) Prevalence (million) Estimated population 
Africa 59.7 42.8 384.4 
Americas 85.4 57.8 125.7 
South-East Asia 42.9 28.7 945.2 
Europe 22.6 14.3 450.8 
East Mediterranean 20.2 13.2 309.6 
Western Pacific 45.7 30.1 986.7 
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and yellow or green in colour (Swygard, 2004). It is caused by an influx in 
polymorphonuclear leukocytes in response to inflammation caused by T. vaginalis and 
possibly by the parasite releasing a chemotactic factor (Demirezen, Safi and Beksaç, 
2000). Strawberry cervix or colipitis macularis is another specific symptom for 
trichomoniasis where the urogenital mucosa develops haemorrhagic spots and, although 
this is the most indicative symptom of T. vaginalis infection, it is only diagnosed in 2-
5% of patients (Lehker and Alderete, 2000). Trichomoniasis is more common in women 
than men (CDC) and around 80% of cases are asymptomatic (Allsworth, Ratner and  
Peipert, 2009). 
 
The general symptoms of trichomoniasis are easily treatable with antibiotics 
whereas the complications associated with trichomoniasis are more severe. T. vaginalis 
infection has been associated with adverse pregnancy outcomes such as low birth 
weight and pre-term birth (Cotch et al 1997; Silver et al., 2014), infertility, an increased 
susceptibility to HIV infection (Quinlivan et al., 2012; Kissinger and Adamski, 2013) 
and an increased risk of cervical cancer (Tao et al., 2014; Yang et al., 2018). 
The recommended treatment for T. vaginalis infection is the use of 5’nitromidiazoles. 
Metronidazole (MTZ) is the FDA approved drug for the treatment on trichomoniasis. 
After its synthesis in 1959 (Cosar and Julou 1959) it was approved in 1960 as the main 
course of treatment for trichomoniasis. Tinidazole can also be used to treat 
trichomoniasis (CDC, 2017). In regard to vaginal trichomoniasis, MTZ resistance 
occurs in 4-10% of cases and tinidazole resistance occurs in 1% of cases in the US 
(Kirkcaldy et al., 2012; Schwebke and Barrientes, 2006) There have been reports of 
increased prevalence of Trichomonas vaginalis resistance in Papua New Guinea ~ 17% 
(Upcroft et al., 2009).  
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1.2.2. Cell Organisation  
 
Discovered in 1836 by Alfredo Francois Donné T. vaginalis is a flagellated 
microaerophilic protozoan with the typical structure and organisation of a trichomonad. 
Its size ranges between 7 and 9 µM and free-swimming trophozoites are pyriform in 
shape with four anterior flagella and one recurrent flagellum that runs down the axis of 
the trichomonad cell and is attached to form the undulating membrane. Upon 
cytoadhesion to epithelial cells the trophozoite becomes amoeboid in shape (Arroyo et 
al., 1993).  
 
The parasites nucleus is located at the anterior portion of the cell and is 
contained within a porous nuclear envelope (Honigberg and King, 1964).  The main 
cytoskeleton structures within the trichomonad cell are the pelta-axostylar complex and 
the costa (Benchimol, 2004). The axostyle is a string of microtubules, arranged 
longitudinally, that runs from the posterior to the anterior end of the cell (Benchimol et. 
Al., 2000). The pelta is located in the anterior part of the cell and is also made up of 
microtubules (Ribeiro et al., 2000). The region where the two sheets of microtubules 
overlap and are connected via bridges is known as the pelta-axostylar junction 
(Honigberg et al., 1971; Benchimol et al., 1993). The costa cytoskeletal complex is a 
striated fibre, made up of proteins organised into filamentous structures, that supports 




T. vaginalis lack mitochondria and instead have anaerobic hydrogenosomes, 
double-membraned organelles which produce ATP through substrate level 
phosphorylation with pyruvate and malate and generate hydrogen as an end product 




Figure 1.4 Trichomonas vaginalis Structure.  Drawing highlighting the main components of a 
pyriform T. vaginalis cell. AF - anterior flagella; AX - axostyle; C - costa; H - hydrogenosome; N 
- nucleus; PB - parabasal body; PG - parabasal body and golgi apparatus; RF - recurrent flagellum. 
Adapted from Barratt et al., (2016) 
 
 
1.2.3. Life Cycle and Population Structure 
 
T. vaginalis exists only in a trophozoite stage and is transmitted via sexual contact. The 
parasite divides by binary fission within the urogenital tract (Figure 1.5) and is 
transmitted by vaginal or prostatic secretions. Pseudocyst forms of the parasite have 
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been observed and are formed when the parasite is under stressful conditions (Pereira-
Neves, Ribeiro and Benchimol, 2003). Isolates have also been taken from the 
respiratory tract in a small number of cases with T. vaginalis identified as the cause of 
respiratory tract symptoms (Carter and Whithaus, 2008) (McLaren LC et al., 1983) 
(Press et al., 2001) (Duboucher et al., 2003). Rare transmission of T. vaginalis via 
fomites has been described in one study in Zambia (Crucitti et al., 2011). Upon 
examination of T. vaginalis genome genes for meiotic recombination machinery have 
been found (Malik et al 2008) but meiosis or has never been observed within T. 
vaginalis.  
 
Figure 1.5: Trichomonas vaginalis Transmission and Life Cycle (CDC available at: 
https://www.cdc.gov/dpdx/trichomoniasis/index.html) 
 
Clinical isolates of T. vaginalis show a high frequency of variation in 
pathogenicity, virulence and antibiotic resistance and studies have used a variety of 
methods to examine the genetic diversity of the parasite as an explanation to the 
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differences between isolates. Earlier work on genetic diversity of T. vaginalis involved 
isoenzyme analysis and antigen characterisation (Soliman et al., 1982; Krieger et al., 
1985). Later studies utilised large samples and random amplified polymorphic DNA 
(Snipes et al., 2000), single nucleotide polymorphisms and microsatellite genotyping 
(Conrad et al., 2012) with statistical programmes to analyse phylogeny and population 
genetics to determine a ‘two type’ population structure in T. vaginalis. The 2012 study 
by Conrad et al., examined 235 T. vaginalis isolates from across the globe to confirm 
the presence of a ‘two population’ structure within Trichomonas vaginalis. The study 
used genetic markers to conclusively demonstrate a global distribution of ‘type 1’ and 
‘type 2’ T. vaginalis population types. The types were found to be equally distributed 
worldwide, with the exception of South Africa and Mexico where a higher frequency 
of type 1 was calculated. The differences found between the two isolates involved the 
minimum lethal concentration (MLC) of antibiotic required to kill isolates and infection 
with the Trichomonas vaginalis virus (TVV). Type 1 isolates required a lower 
concentration of MTZ to be killed with a mean of 76.6 µg/ml compared to type 2 which 
had a mean MLC of 228.4 µg/ml. Type 1 isolates were more frequently infected with 
TVV compared to Type 2. These findings correlate with findings from Snipes et al., 
(2000) and Cornelius et al., (2012). Phylogenetic analysis suggests type 1 is the 
ancestral type which type 2 diverged from (Conrad et al., 2012).  
 
1.2.4. Pathogenesis  
 
Trichomonas vaginalis is a microaerophilic parasite which utilises the human urogenital 
tract as its niche where it exists extracellularly. T. vaginalis deploys a number of 
virulence mechanisms to colonise the human urogenital tract. Differences in the 
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microenvironments of female and male urogenital tracts may affect the parasites ability 
to colonise and explain the difference between men and women’s ability to clear T. 
vaginalis infection. The vaginal mucosa is rich in iron required for the parasite’s 
survival (Lehker, 1990) whereas the prostatic glands of the penis have a hostile zinc 
rich environment. Zinc is antimicrobial and concentrations of zinc salts, similar to 
concentration found in the prostatic fluid, were found to kill trichomonads in vitro (Fair, 
Couch and Wehner, 1976; Krieger and Rein, 1982) 
 
Once transmitted the free swimming trophozoites remain extracellular and 
adhere to squamous epithelial cells. Cytoadherence is essential for establishment of 
infection, and during adhesion the parasite undergoes a conformational change from 
pyriform to amoeboid and adhesion expression is increased (Arroyo et al., 1993). The 
process of cytoadherence and involves the surface proteins adhesins and 
glycoconjugates as well as cytoskeletal proteins and extra-cellular matrix (ECM) 
protein receptors (Figueroa-Angulo et al., 2012). 
 
The parasite overcomes the host’s mucous layer, an innate immune defence, by 
binding and releasing mucinases that degrade the mucin glycoprotein (Alderete et al., 
2002) After successful adherence colonisation of vaginal epithelial cells (VECs) is 
initiated by the parasite via a multistep process that results in cytolysis, phagocytosis 
and disintegration of cell monolayers (Figueroa-Angulo et al., 2012). Contact-
independent mechanisms also damage host tissues, T. vaginalis secretes cytolytic 
factors to aid in colonisation including; Trichomonas vaginalis factor (TvF) and cell 
detaching factor (CDF). TvF induces clumping of target cells and CDF promotes cell 
detachment (Lushbaugh et al., 1989). 
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Some T. vaginalis isolates harbour a double stranded RNA virus. The T. 
vaginalis virus is a member of the Totiviridae virus family which parasitizes T. 
vaginalis (Goodman et al., 2010). Four species of TVV have been reported and multiple 
strains can infect one single isolate causing a mixed infection (Flegr, Čerkasov and 
Štokrová, 1988; Goodman et al., 2011). As previously mentioned, Type 1 isolates 
appear to be more frequently infected with TVV, Conrad et al., (2012) analysis of 153 
isolates showed 75% of type 1 were infected compared to only 3% of type 2. TVV has 
been linked to upregulation of cysteine proteases, virulence factors which degrade 
proteins involved in the immune response and immunoglobulins (Alderete, Provenzano 
and Lehker, 1995; Provenzano and Alderete, 1995). Cysteine proteases are also 
involved in cytoadherence (Arroyo and Alderete, 1989). Upregulation of cysteine 
proteases could confer advantage for the parasites’ survival within the human urogenital 
tract.    
 
In addition to TVV T. vaginalis isolates can also harbour the bacterium 
Mycoplasma hominis (M. hominis) (Rappelli et al., 1998; Vancini and Benchimol, 
2007) and Candidatus Mycoplasma girerdii (C. M. giredii) (Martin et al., 2013; 
Fettweis et al., 2014).  M. hominis is a T. vaginalis symbiont which has been reported 
to contribute to the pathogenicity of T. vaginalis by increasing growth rate and ATP 
production (Margarita et al., 2016). In vitro studies have shown M. hominis infected T. 
vaginalis strains to have an enhanced rate of cytopathogenicity of epithelial cells and 
haemolysis of red blood cells compared to non-infected strains (Vancini et al., 2007; 
(Margarita et al., 2016).  M. hominis has been linked to bacterial vaginosis, adverse 
pregnancy outcomes and pelvic inflammatory disease (Larsen and Hwang, 2010). 
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1.2.5. Genome  
 
The draft genome for the Trichomonas vaginalis G3 lab isolate was first published in 
2007 allowing more research to be done on the parasites’ genetic diversity, population 
structure and pathogenesis. The draft genome sequence, originally stated as ~160 Mb 
in size with more recent data stating ~176 Mb (TrichDB.org), contains around 46,000 
protein coding genes on six haploid chromosomes (Carlton et al.,2007) Around 65% of 
the genome is composed of transposable elements. The T. vaginalis genome is 
considerably large compared to other parasitic protists genomes; Leishmania major (32 
Mb) (Ivens et al., 2005), Toxoplasma gondii (65 Mb) (Lau et al., 2016) and Plasmodium 
falciparum (22 Mb) (Gardner et al., 2002). This larger size of the genome could be 
explained by genome duplication events (Carlton et al., 2007).  
 
1.2.6. Horizontal Gene Transfer 
 
Horizontal gene transfer (HGT), or lateral gene transfer (LGT), refers to the non-sexual 
transmission of genes between two organisms. It is widely documented in prokaryotes 
via transformation, conjugation and transduction (von Wintersdorff et al., 2016). 
Instances of horizontal gene transfer between prokaryotes and eukaryotes are less well 
understood. However, phylogenomic studies have estimated 0.25% of T. vaginalis 
genes are acquired by LGT (Alsmark et al., 2013).  T. vaginalis lives within the human 
urogenital tract, an ecological niche inhabited by several species of bacteria, viruses and 
fungi, which are part of the normal microbiota of humans (Pruski et al., 2018). Within 
this niche HGT can occur and has been widely documented in T. vaginalis. Strese, 
Backlund and Alsmark (2014) analysed a 34 kbp region of the T. vaginalis genome, the 
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Trichomonas vaginalis lateral gene transfer fragment (TvLF), and concluded it was 
probably a result of a single lateral gene transfer event from a Peptoniphilus harei 
donor. 
 
Horizontal gene transfer is a way of picking up advantageous genes to enrich 
survival, and in T. vaginalis’ case, to increase pathogenicity. Work by Alsmark et al., 
(2013) identified nine T. vaginalis enzymes involved in the degradation of glycans in 
host cell membranes as products of gene transfers, highlighting the significance HGT 
has had within the parasite. The BSPA-like proteins are also likely to have been 
acquired by T. vaginalis via horizontal gene transfer from ancient prokaryotes (Noël et 
al., 2010).  Trichomonas vaginalis has also been documented to be involved in 
eukaryote to eukaryote HGT. Several HGTs have been identified between the human 
parasite Entamoeba histolytica (E. histolytica) and T. vaginalis. Grant and Katz (2014) 
propose an ancestral relationship between the two human parasites which allowed them 
to take part in horizontal gene transfer.  
 
One hypothesis on the mechanism of HGT between prokaryotes and 
eukaryotes is that gene transfer is mediated by phagocytosis, the ‘you are what you 
eat’ hypothesis (Doolittle, 1998). T. vaginalis uses phagocytosis to ingest necrotic 
tissue after the break down of host cell membrane during infection and it has been 
shown that T. vaginalis is able to phagocytose Saccharomyces cerevisiae, lactobacilli, 
leukocytes and erythrocytes in-vitro (Midlej and Benchimol, 2009; Pereira-Neves and 
Benchimol, 2007; Rendón-Maldonado et al., 1998).  The ‘you are what you eat’ 
hypothesis could explain the high percentage of HGT within the T. vaginalis genome.  
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Synthetic genes and oligonucleotide primers were obtained from Thermo Fisher 
Scientific. Fluorescently labelled substrate oligonucleotides, deoxyinosine (dI), 
deoxythymidine (dT), deoxycytidine (dC) and 8oxoG, were obtained from Sigma or 
from Eurogentec (deoxyuridine (dU)) All other chemicals were purchased from Sigma 
unless otherwise stated. Escherichia coli Competent cells were obtained from Novagen, 
Escherichia coli Rosetta(DE3)pLysS cells (Rosetta™) and New England BioLabs 
Escherichia coli Turbo high efficiency cells (Turbo)  genotypes for both strains can be 
found in Table 2.1. 
 
Strain Genotype 
Rosetta™ F- ompT hsdSB(rB- mB-) gal dcm pRARE (CamR) 
Turbo F' proA+B+ lacIq ∆lacZM15 / fhuA2  ∆(lac-proAB)  glnV galK16 galE15  R(zgb-
210::Tn10)TetS  endA1 thi-1 ∆(hsdS-mcrB)5   
 
Table 2.1 E.  coli Competent Cell Genotypes. The genotypes of Rosetta (DE3)pLysS cells 






2.2.1. Molecular Cloning 
 
2.2.1.1 Preparation of Competent Cells 
 
Escherichia coli Rosetta(DE3)pLysS cells (Novagen) were spread on LB agar plates 
(Table 2.2) with chloramphenicol (34 µg/ml) and incubated at 37°C overnight. A single 
colony was used to inoculate 5 ml of LB broth (Table 2.2) which was incubated with 
shaking overnight or for 8 hours at 37°C. After incubation, 0.5 ml of the culture was 
used to inoculate 50 ml LB broth which was incubated with shaking until an optical 
density (OD) of 0.6 was reached. OD was measured using a spectrophotometer with 
distilled water (dH2O) water as a blank measurement. The culture was transferred into 
50 ml Oakridge tubes, chilled on ice and centrifuged in an Avanti-JX centrifuge using 
a JA 25.50 rotor (Beckman Coulter Inc.) at 3000 g, 4°C for 5 minutes. After 
centrifuging, the supernatant was discarded, and tubes were inverted to ensure all traces 
of supernatant were removed. The pellet was re-suspended into 0.4 volumes ice cold 1 
M Calcium Chloride (CaCl2). The culture was left to incubate on ice for 30 minutes and 
cells were harvested by centrifugation with the same settings as previously described. 
After removal of the supernatant the cells were re-suspended in 3 ml ice cold CaCl2 and 
1 ml 50% glycerol. Newly prepared competent cells were snap-frozen and stored in 




2.2.1.2 Transformation of Bacterial Cells 
 
New England BioLabs (NEB) Turbo competent high efficiency E. coli cells were used 
for the propagation of plasmids and E. coli Rosetta (DE3)pLysS cells were used for 
protein expression. Cells were thawed and 2 µl of plasmid, ligation mixture or site 
directed mutagenesis reaction mixture were added. The culture was heat shocked at 
42°C for 30 seconds and left on ice for 2 minutes. 200 µl of S.O.C medium (NEB) was 
added and the culture was incubated with shaking at 160 rpm 37°C for 1 hour. After 
incubation, 50 µl was spread on LB agar plates (Table 2.2) containing the appropriate 
antibiotics (Table 2.3) and incubated at 37°C overnight. Plates were wrapped with 
parafilm and stored in the 4°C fridge until use.   
 
 
Table 2.2 Composition of Media used for Bacterial Cell Growth.  
 
Name  Composition Manufacturer 
LB broth 
0.5% Yeast Extract 
1% Tryptone 
1% NaCl 
Scientific Laboratory Supplies (SLS) Ltd 
SLS Ltd 
Sigma Aldrich  
LB agar  
0.5% Yeast Extract  
1% Tryptone 




Sigma Aldrich  
SLS Ltd 
SOC media  
2% Vegetable Peptone 
0.5% Yeast Extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
10 mM MgSO4 
20 mM Glucose 






Table 2.3: Details of Stock Solutions of Antibiotics used for Selection of Resistant E. coli 
Colonies and Cultures. Stock solutions were added to medium at a dilution of 1:1000. DMSO - 
Dimethyl sulfoxide  
 
 
2.2.1.3 Plasmid DNA Preparation  
 
A single colony of previously transformed NEB Turbo cells was used to inoculate 5 ml 
of LB broth with appropriate antibiotics (Table 2.3) and incubated with shaking at 37°C 
160 rpm for 8 hours or overnight. After incubation, the culture was centrifuged at 5000 
rpm for 15 minutes at 4°C and the resulting pellet was frozen at -80°C or purified using 
the GeneJET Plasmid Miniprep kit (Thermo Fisher Scientific) according to 
manufacturer instructions. The concentration of the purified plasmid DNA was 
measured using a NanoDrop UV-Vis spectrophotometer (Thermo Fisher Scientific) at 






Chloramphenicol  34 in DMSO 
Kanamycin  30 in dH2O 
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2.2.1.4 Restriction Digest 
 
The plasmid containing the artificially synthesised TVAAG2 insert and pET28a 
expression vector were each cut with NdeI and XhoI restriction enzymes (NEB). The 
restriction digest mixture (Table 2.4) was incubated at 37°C for 2 hours. Samples were 
covered with tinfoil in the dryblock incubator during incubation to prevent evaporation. 
 
 










 Restriction mixture composition Final concentration  
TvAAG2 
TvAAG2 vector  
NdeI 
XhoI 






Up to 20 µl 
pET28a 
pET28a expression vector  
NdeI 
XhoI 








Up to 30 µl  
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2.2.1.5  Agarose Gel Electrophoresis  
 
Electrophoresis analysis of the digested plasmids from section 2.2.14 was carried out 
on agarose gel with 0.5 X TBE buffer (Table 2.5) at 90-120 V for 1 hour to determine 
if the restriction digest was successful. Plasmid DNA samples were prepared by adding 
DNA loading dye and ran alongside a DNA molecular marker (Table 2.5). The gel was 









Name Composition  
Agarose gel  TBE buffer  
Agarose 
GelRed 
0.5 X  
0.24 g 
1:10000 






6 x DNA loading buffer  Tris-HCl  
Bromophenol blue,  
 Xylene cyanol FF 
 Glycerol 
EDTA.  





DNA molecular marker  100 bp DNA Ladder New England Biolabs  
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2.2.1.6 Purification of DNA Fragments  
 
Appropriate bands identified with the UV transilluminator in section 2.2.1.5 were cut 
out with a razor blade and purified using the QIAEX II Agarose gel extraction kit 
(QIAGEN). According to manufacturer instructions. 
 
2.2.1.7 Ligation of DNA into Vector 
 
The ligation reaction mixture for the TvAAG2 insert and pET28a expression vector 
(Table 2.6) was incubated for 15 minutes at room temperature. 2 µl of the reaction 
mixture was used to transform Turbo competent cells which were grown on LB agar 
plates. 
 
Single colonies from these plates were used to inoculate 5 ml cultures and 
plasmids prepared as described in Section 2.2.1.3. Plasmids were screened by restriction 
digestion as described in Section 2.2.1.4 and 2.2.1.5. If a band at the right size was 
visualised from restriction digestion the same plasmid was sent for Sanger sequencing 










Table 2.6 Composition of Ligation Reaction Mixture. Components from New England Biolabs. 
 
2.2.2. Protein Expression and Purification 
 
2.2.2.1 Test Expression 
 
5 ml LB broth ‘starter’ cultures were inoculated with a single colony from previously 
transformed Rosetta 2 (DE3) pLysS cells (as described in 2.2.1.2) with the appropriate 
antibiotics and left to grow for 8 hours or overnight. These starter cultures were used to 
inoculate 50 ml of LB with the appropriate antibiotics and incubated with shaking at 
160 rpm at 37°C for 3 hours until mid-log phase which was confirmed by OD 
measurement of 0.6 or above using UV-vis spectrophotometry. 1 ml of the culture was 
taken to be processed for subsequent analysis by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) and Isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to the remaining culture to a final 
concentration of 1 mM to induce protein expression. The culture was incubated for a 
further 3 hours with 1 ml samples taken at hour intervals and processed for SDS-PAGE. 
This involved samples being spun down in a microcentrifuge at 600 rpm, supernatant 
discarded, and the pellet resuspended in 200 µl of 1 X SDS-PAGE loading buffer before 
heating in a 95°C heat block for 3 minutes. Samples were stored at -20°C. 10 µl of each 
Ligation mixture composition  Final concentration 








Up to 20 µl 
1 µl 
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of the thawed samples were loaded onto a 10% SDS-PAGE gel (described later in 
Section 2.2.2.6) alongside 5 µl of molecular weight marker.  
 
2.2.2.2 Large Scale Expression 
 
5 ml starter cultures were grown as previously described (Section 2.2.2.1) and added to 
750 ml LB cultures with the appropriate antibiotics and incubated with shaking 160 rpm 
at 37°C for 3 hours until mid-log phase was reached. IPTG was added to a final 
concentration of 1 mM and the culture was left to grow for a further 3 hours. After 
growth the cultures were transferred to 1 L polypropylene centrifuge bottles (Beckman 
Coulter Inc) and centrifuged in an Avanti-JX centrifuge using the JLA 8.1000 rotor 
from Beckman Coulter Inc at 3000 rpm for 20 minutes, 4°C. The supernatant was 
discarded, and the cell lysate pellet was frozen at -80°C for later use.  
 
 
2.2.2.3 Preparation of the Cell Lysate 
 
The frozen cell lysate pellet was left to thaw on ice. One tablet of protease inhibitor 
(cOmplete ULTRA Tablets Mini EDTA Free, Sigma Aldrich) was dissolved in 10 ml 
of cold buffer A (Table 2.7) and left on ice for 15 minutes. This buffer was used to 
resuspend the cell lysate pellet. The resuspended sample was sonicated to lyse the 
bacterial cells. Sonication was done 5 times for a total of 15 seconds with a 15 second 
break between each sonication. The sample was kept in an ice-water bath during 
sonication to ensure no degradation of protein. The sonicated sample was transferred to 
Oakridge tubes and centrifuged in an Avanti JX centrifuge using a JLA 25.25 rotor at 
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20,000 rpm for 30 minutes, 4°C. The cell lysate was used in subsequent purification 
steps and the pelleted cell debris discarded. 
 
2.2.2.4 Nickel – Nitrilotriacetic Acid Affinity Column Chromatography  
 
The resin used for the Nickel - Nitrilotriacetic acid (Ni-NTA) purification column was 
made by adding 300 µl resin (QIAGEN) to the cell lysate (step 2.2.2.3) which was 
incubated on a rotator for 30 minutes, 4°C. The resin-cell lysate mixture was passed 
through the Ni-NTA column and unbound protein was collected as the ‘’flow through’’ 
fraction. 1.2 ml of Buffer A was used for the first wash (Wash 1) and 1.2 ml of 10% 
buffer B (Table 2.7) in A was used for the second wash (Wash 2). 600 µl of buffer B 
was used to elute the purified protein (Elute). The fractions were prepared for SDS-
PAGE (Section 2.2.2.6) to analyse the purification of protein. All steps were done at 
4°C to prevent protein degradation. 
Table 2.7 Composition of Buffers used in Ni-NTA Chromatography  
 
 
Name Composition  
Buffer A 50 mM NaH2PO4 
1 M NaCl 
10 mM Imidazole 
Buffer B 
 
50 mM NaH2PO4 
1 M NaCl 
250 mM Imidazole 
Protein Dialysis Buffer  50 mM HEPES  
100 mM NaCl 
1 mM DTT 





If a protein band could be seen at the appropriate molecular weight following SDS-
PAGE the final eluted fraction was dialysed in pre-cooled protein dialysis buffer (PDB) 
(Table 2.7). The fraction was inserted into a dialysis cassette from Invitrogen using a 
fresh syringe. The cassette was left in a beaker of PDB on a magnetic spinner overnight. 
After overnight dialysis the protein was removed from the dialysis cassette and 
centrifuged at 13,000 rpm for 10 minutes at 4°C. The concentration of the protein was 
calculated using a UV-vis spectrophotometer. 
 
2.2.2.6 SDS-PAGE  
 
SDS PAGE gels were hand cast using the Mini-PROTEAN Tetra Cell casting stand 
system and glass plates from Biorad or precast Novex Tris-Glycine midi protein gels 
were used. For hand cast gels 10% resolving gel (Table 2.8) was poured between the 
glass plates. 1-butanol was poured onto the top of the 10% resolving gel to prevent 
quenching of polymerisation by air and to ensure no bubbles were present before 
pouring of stacking gel. After gel polymerisation 1-butanol was washed off the top of 
the gel and 4% stacking gel (Table 2.8) was poured onto the top. A 1 mm 12 or 15 well 
comb was inserted, and the gel was left to polymerise. Samples for SDS-PAGE were 
mixed with 3 X or 2 X SDS loading buffer, heated for 5 minutes at 95°C and loaded 
onto the gels alongside a protein ladder. Hand cast gels were ran for 1 hour 30 minutes 
in a Mini-PROTEAN Tetra vertical electrophoresis cell at 200 V. Precast gels were ran 
with the mini gel tank (Thermo Fisher) at 225 V for 45 minutes. Both gels used 1 X 
TGS running buffer and were stained with Coomassie Blue dye and left overnight to 
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stain. Gels were imaged using a ChemiDoc XRS+ from Biorad with the Fluro orange 
option on Image Lab Software.  
 
 







Name Composition  
10% Resolving gel 4% Acrylamide  





4% Stacking gel 10% Acrylamide 





1 X Tris Glycine SDS buffer  25 mM Tris,  




2.2.3. Preparation of TvAAG1 and TvAAG2 Mutants 
 
2.2.3.1 Designing Site Directed Mutagenesis Primers 
 
Amino acids of interest were identified using BLAST search to find closely related 
species to T. vaginalis with TvAAG homologs. These organisms were used in a 
Clustal Omega Alignment to identify conserved regions of the proteins. The only 
lysine conserved between all of the identified homologs was chosen as a mutation 
target. For TvAAG1 and TvAAG2 there would be a Lysine à Arginine (Arg) 
mutant and Lysine à Alanine (Ala) mutant. Site directed mutagenesis primers 
(Table 2.9) were designed using Quikchange Primer Design Program at Aglient 
genomics website.  

























Point mutation lysine to 
arginine  




2.2.3.2 Phusion Flash Site Directed Mutagenesis 
 
Site directed mutagenesis was carried out in a thermal cycler. The reaction mixture 
(Table 2.10) was put in a thermal cycler to run with the Phusion flash programme 
(Table 2.11). Following completion of this step, restriction enzyme DpnI (10 U) was 
added and the reaction incubated at 37oC for a further 1 hour. After site directed 
mutagenesis the reaction mixture was used to transform Turbo cells as described in 
part 2.2.2.1.  
Table 2.10 Composition of the Site Directed Mutagenesis Reaction Mixture. 
 
  
Table 2.11 Phusion Flash PCR Cycling Instructions. 
 
Composition  Volume 
2 X Phusion Flash PCR Master Mix  








10 mM dNTP  1 µl 
Template 1 µl 
dH2O 20 µl 
Step Temperature (°C) Time (s) Cycles (no.)  
Initial denaturation 98 10 1 
Denaturation 98 1 30 











2.2.4. Glycosylase Activity Assays 
 
Glycosylase activity was assessed by measuring the intensity of fragments produced by 
cleavage of fluorescently-labelled oligonucleotide substrates by glycosylases resolved 
by denaturing PAGE. The resulting fragments of cleavage would be shorter in length, 
18 oligomer (mer) compared to the original 39 mer substrate and will migrate further in 
the denaturing urea polyacrylamide gel according to its molecular weight. The substrate 
oligomer was labelled with a Cy5 fluorescent label to allow imaging. 
 
2.2.4.1 Enzyme Activity Assay Samples 
 
Enzyme dilutions of 1 µM - 1 nM were made from previously purified protein stock 
(Section 2.2.2) using 10% bovine serum albumin (BSA) in PDB as dilution buffer. 2 µl 
of each dilution and 2 µl of PDB/BSA as a negative control were added to 18 µl of 
master mix, containing the substrate to be tested, in separate Eppendorf tubes (Table 
2.12) and heated at 37°C for 15 minutes. Tinfoil was used to cover the Eppendorf’s to 
prevent condensation. FA/NaOH was added to stop the reaction and samples were either 
frozen in -20°C or processed straight away. Samples were heated at 95°C for 5 minutes 
and then loaded onto a urea polyacrylamide gel. 
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2.2.4.2 Denaturing Urea Polyacrylamide Gel Electrophoresis  
 
Urea polyacrylamide gel was hand cast using the Mini-PROTEAN Tetra Cell casting 
stand system and glass plates from Biorad and prepared according to the composition 
in Table 2.13 The gel was poured between the glass plates on the casting stand system 
then a 1 mm 12 or 15 well comb was inserted and the gel was left to polymerise. The 
gel was pre-ran at 200 V for 30 minutes in the BioRad Mini-PROTEAN Tetra vertical 
electrophoresis cell before loading the samples which ran at 200 V for 1 hour. After 
electrophoresis the glass plates were imaged using the ChemiDoc XRS+ Cy5 blot 
option.  
 




Enzyme Activity Assay Master Mix Concentration  
Glycosylase buffer 50 mM HEPES 
50 mM NaCl 
10 mM DTT 
1 mM EDTA 
DNA substrate 50 nM 
BSA  0.1 mg/ml 
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2.2.5. Schiff Base Assay 
 
The Schiff base assay was used to assess the glycosylases to determine if they were 
monofunctional or bifunctional.  A master mix for the assay was made up as according 
to Table 2.12 and 1 µl of the protein and either 1 µl of dH20 or 25 mM cyanoborohydride 
was added. Samples were run on SDS-PAGE gels as described in 2.2.2.6 and imaged 





Urea gel  Urea gel                          79.53% 
5x Urea buffer                 14.88% 
APS                                  0.53% 
TEMED                            0.53% 
Urea buffer Urea  
10x TBE 
MilliQ water  
FA/NaOH  Formamide 
1 M NaOH 
Blue dextran  
TBE buffer  10x TBE buffer (Severn Biotech Ltd)  
dH2O  
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2.2.6. Bioinformatic Analysis  
 
To generate the atlas of DNA repair enzymes found in T. vaginalis and Tritrichomonas 
foetus (T. foetus) the NCBI database was used to obtain the amino  
acid sequence for various human DNA repair enzymes which were used with the Basic 
Local Alignment Search Tool (BLAST) to identify homologs. Alignments were put 
together using the FASTA sequences of these homologs and Clustal OMEGA.  
 
2.2.6.1 BLAST  
 
BLAST search (available at the NCBI website) was used to identify homologs of 
common human DNA repair enzymes in T. vaginalis and T. foetus. Reliability of the 
results was assessed using the expected value (E value). The E value describes the 
number of hits that are expected to be found by chance, results with an E value less than 
1e-4 were acceptable and results with a higher value discarded or analysed further using 
reciprocal BLAST the NCBI conserved domains database and Clustal OMEGA 
alignments.  
 
2.2.6.2 Clustal OMEGA Alignments  
 
Clustal OMEGA (accessed at: www.ebi.ac.uk/Tools/msa/clustalo/) was used to create 
multiple sequence alignments using FASTA sequences copied from NCBI. The 
resulting alignment was copied into BoxShade (accessed at: https://embnet.vital-
it.ch/software/BOX_form.html) to colour the alignment according to conservation of 
amino acids.   
 61 
3  
Bioinformatic Analysis of DNA Repair Pathways 
in Trichomonas vaginalis and  





The aim of this section of my work was to create an atlas of DNA repair enzymes and 
proteins for Trichomonas vaginalis and Tritrichomonas foetus.  I performed 
bioinformatic analysis across four major DNA repair pathways, including the proteins 
named TvAAG1 and TvAAG2, which were to be characterised in the biochemistry arm 
of my project. I also determined the presence of AAG and DNA methyltransferase 
enzymes within a range of species from all kingdoms of life. Another aim of this section 











3.2. Analysis of DNA Repair Proteins  
 
Human DNA repair enzymes involved in base excision repair, mismatch repair, non-
homologous end joining, and homologous recombination were identified and used to 
find possible homologs in T. vaginalis and T. foetus. BLAST search (Altschul et al., 
1990) was used with each gene’s nucleotide accession number as a query within the T. 
vaginalis G3 (taxid:412133) and T. foetus (taxid:1144522) protein database. Hits were 
deemed acceptable if they had an E value below 1e-4 and an alignment score above 80. 
Any hits with an acceptable E value were checked by doing a reciprocal BLAST search; 
using the resulting protein accession number as a query in a BLAST search against the 
Homo sapiens database to see if the original query gene was the top hit. If more than 
one query gene resulted in the same hit, or if the reciprocal BLAST showed a different 
gene, further analysis was carried out. Further analysis involved; looking for common 
conserved domains using the NCBI Conserved Domain Database (CDD) (Marchler-
Bauer et al., 2016) and analysis of sequences by multiple sequence alignment using the 
CLUSTAL Omega programme at The European Bioinformatics Institute website 
(https://www.ebi.ac.uk/Tools/msa/clustalo/). 
 
3.2.1. Base Excision Repair 
 
Base excision repair removes single base lesions caused by oxidative and alkylation 
damage as described in Section 1.1.1.1 and Section 1.1.1.2. The main DNA repair 
enzymes within the BER pathway are DNA glycosylases which recognise the damaged 
base and act to excise the base which generates an AP site (Lindahl, 1993). DNA 
glycosylases can be monofunctional or bifunctional. Bifunctional glycosylases have 
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intrinsic b-lyase or b/d-lyase activity allowing the enzyme to cleave the DNA backbone 
after generation of AP site to leave a strand break. Following excision by 
monofunctional glycosylases, a class of enzymes known as AP endonucleases remove 
the AP site to generate a strand break. The strand breaks generated by bifunctional 
glycosylases or AP endonucleases are further processed by DNA polymerases and 
joined by DNA ligase. DNA glycosylases recognise different DNA lesions and twelve 
DNA glycosylases have been identified within mammals which are present in humans.  
Most notably OGG1 which removes the highly mutagenic 8-oxoguanine lesion and 
UDG which removes uracil. 
 
I used a list of nucleotide accession numbers, for a total of 23 genes, involved 
in human BER to identify which were conserved within T. vaginalis and T. foetus. The 
list comprised of twelve glycosylases, three endonucleases, two DNA ligases, three 
DNA polymerases and four accessory proteins. Table 3.1 shows the genes involved in 
base excision repair within T. vaginalis and T. foetus. Six of the genes analysed encode 
proteins involved in replication and are highlighted in Table 3.1. Proteins involved 
DNA repair and replication would be expected to be conserved within the parasites due 
to their replicative function. This is true for both T. vaginalis and T. foetus as almost all 
of the genes that encode for proteins involved in replication are conserved. The only 
exception to this is that T. vaginalis does not have a Pole homolog and T. foetus does 
not have a Pold homolog.   
 
Out of the 23 genes analysed T. vaginalis had eleven significant hits: three 
glycosylases, two endonucleases (i.e. Apurinic/apyrimidinic endonuclease 1 (APE1) 
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and Flap endonuclease 1 (FEN1)), one DNA ligase, one polymerase, PCNA and RF-C. 
Two homologs were identified for MPG and APE1.  
T. foetus also had eleven hits, three glycosylases, two endonucleases, one DNA ligase, 
one polymerase, PCNA and RF-C. T. foetus differs from T. vaginalis as it has two 



























Uracil DNA N-glycosylase 
NM_003362 XP_001296939.1 OHS99142.1 
UDG2 
Uracil DNA N-glycosylase 2 





NM_014311 x x 
OGG1 
8-Oxo-guanine glycosylase 1  
NM_016821 x x 
TDG 
Thymine DNA glycosylase 




NM_003925 x x 
MYH 
Mut Y homolog DNA 
glycosylase 
NM_012222 x x 
NTH1 
Endonuclease three homolog 
1 DNA glycosylase 
NM_002528 XP_001329048.1 OHT05554.1 
OHS93885.1 
MPG 







Nei-like DNA glycosylase 1 
NM_024608 x x 
NEIL2 
Nei-like DNA glycosylase 2 
NM_145043.3 x x 
NEIL3 
Nei-like DNA glycosylase 3 











NM_014481 x x 
LIG I 






DNA ligase 3 
NM_013975 x x 
Polβ 
DNA polymerase b 
NM_002690 x x 
Polε 
DNA polymerase e 
NM_006231 x OHT04305.1 
Polδ 






complementing protein 1 
NM_006297 x x 
PCNA 
Proliferating cell nuclear 
antigen 
NM_182649 XP_001329442.1 OHT09382.1 
RF-C 











Table 3.1: Genes Involved in Base Excision Repair in Humans and their Homologs in T. 
vaginalis and T. foetus. Gene designations and protein names of common proteins involved in BER 
are listed with the accession numbers for the corresponding human nucleotide sequences. BLAST 
search was used to identify homologs within T. vaginalis (taxid:412133) and T. foetus 
(taxid:1144522). Entries for proteins involved in DNA replication are shaded grey. 
 
During initial analysis on T. vaginalis the same top hit, HhH-GPD superfamily 
base excision DNA repair protein (accession no. XP_001329048.1) was shown for both 
MYH and NTH1. To determine which of these two human glycosylases the T. vaginalis 
protein was most likely to be a homolog of, a reciprocal BLAST was carried out and 
CLUSTAL alignment was produced using the FASTA sequences for MYH, NTH1 and 
the T. vaginalis protein. The alignment is shown in Figure 3.1. Upon analysis of the 
conservation of key catalytic and substrate binding residues, XP_001329048.1 was 
identified as a homolog for NTHL1. This is consistent with the reciprocal BLAST 
search using XP_001329048.1 against the Homo sapiens (taxid:9606) database which 
lists NTH1 with 90% query cover and an expected value of 1e-50 compared to MYH 
which had 61% query cover and an expected value of 0.022.  
 
The results of the BLAST search for MYH and NTH1 within T. foetus resulted 
in the same hits with acceptable E values; the putative endonuclease III like protein 
(OHS93885.1) and the HhH-GPD superfamily base excision DNA repair protein 
(OHT05554.1). Reciprocal searches using both proteins against the H.  sapiens database 
resulted in NTH1 as the top hit. A multiple sequence alignment with OHS93885.1 
confirms it is more similar to NTH1 (Figure 3.2).  The multiple sequence alignment 
with OHT05554.1 also shows it to be more similar to NTH1 than MYH (Figure 3.3) 




Figure 3.1: Multiple Sequence Alignment of Sequences for Human MYH, NTH1 and 
Trichomonas vaginalis XP_001329048.1. The FASTA sequences for the genes were found on the 
NCBI website and used with the Clustal Omega tool on the European Bioinformatics Institute 
website to produce the Clustal alignment. Box shade (ExPASy) was used to highlight identical 




Figure 3.2 Multiple Sequence Alignment of Human MYH, NTH1 and Tritrichomonas foetus 
OHS93885.1. FASTA sequences for the genes were found on the NCBI website and used with the 
Clustal Omega tool on the European Bioinformatics Institute website to produce the  alignment. Box 





Figure 3.3: Multiple Sequence Alignment with Human MYH, NTHL1 and Tritrichomonas 
foetus OHT05554.1. FASTA sequences for the genes were found on the NCBI website and used 
with the Clustal Omega tool on the European Bioinformatics Institute website to produce the 
alignment. Box shade (ExPASy) was used to highlight identical amino acids in black and similar 
amino acids in grey.  
 
 
The BLAST search for APE2 in both T. vaginalis and T. foetus resulted in hits 
(XP_001324898.1 and OHT05750.1 respectively) which, when used in a reciprocal 
blast search, did not come up with the original APE2 query but instead showed APE1. 
A multiple sequence alignment was created using APE1, APE2 and XP_001324898.1 
or OHT05750.1 to test if the proteins were APE1 or APE2 homologs.  Both 
XP_001324898.1 (Figure 3.4) and OHT05750.1 (Figure 3.5) are more similar to APE1 
on the multiple sequence alignments. The original BLAST search with APE1 as a query 
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did show XP_001324898.1 and OHT05750.1 as hits in addition to the top hits of 
XP_001299171.1 (T. vaginalis) and OHT00257.1 (T. foetus). XP_001299171.1 and 
OHT00257.1 showed APE1 when used in reciprocal BLAST searches. Suggesting both 
T. vaginalis and T. foetus have two APE1 homologs.  
 
The BLAST search for DNA polymerase d (NM_002691) in T. foetus listed 
DNA polymerase family B containing protein (OHT08034.1) as a hit with an acceptable 
E value but the reciprocal blast shows it is a polymerase z (NM_002912.4) homolog so 
was not listed in the table.  The same occurred when searching for DNA polymerase d 
homologs with T. vaginalis. A hit with an accepted E value (XP_001303643.1) was 
listed that, when used as the query for a reciprocal blast, is actually a polymerase z 
(Polz) homolog. Pol z is present in mammals and yeast and is involved in translesion 
synthesis, a repair mechanism used to overcome bulky lesions that stall the replication 
fork (Gibbs et al., 1998; Johnson et al., 2000). 
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Figure 3.4 Multiple Sequence Alignment with Human APE1, APE2 and Trichomonas vaginalis 
XP_001324898.1. FASTA sequences for the genes were found on the NCBI website and used with 
the Clustal Omega tool on the European Bioinformatics Institute website to produce the alignment. 
Box shade (ExPASy) was used to highlight identical amino acids in black and similar amino acids 





Figure 3.5 Multiple Sequence Alignment for Human APE1, APE2 and Tritrichomonas foetus 
OHT05750.1. FASTA sequences for the genes were found on the NCBI website and used with the 
Clustal Omega tool on the European Bioinformatics Institute website to produce this Clustal 
alignment. Box shade (ExPASy) was used to highlight identical amino acids in black and similar 
amino acids in grey. 
 
3.2.2. Mismatch Repair 
 
Mismatch repair corrects DNA base substitution mismatches and insertion-deletion 
mismatches (IDLs), that escape the proofreading ability of DNA polymerases generated 
during replication. Studies on MMR in E. coli were the first to establish the basic 
mechanism (Wildenberg and Meselson, 1975; Glickman and Radman, 1980). This 
mechanism involves recognition of the mismatch, excision of newly synthesised strand 
containing the erroneous base and gap filling by re-synthesis of the strand. Prokaryotic 
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MMR uses the mismatch recognition protein MutS to recognise base mismatches and 
to recruit MutL and MutH. The MutS-MutL-MutH complex slides along the template 
DNA strand to find a hemi-methylated GATC sequence a site where the unmethylated 
daughter strand is currently being synthesised. MutH incises at the GATC site on the 
newly synthesised strand, allowing excision of the strand by DNA exonuclease and 
DNA helicase (Lahue and Modrich, 1988., Burdett et al., 2001., Mechanic, Frankel and 
Matson, 2000). DNA polymerase III carries out repair of the single stranded gap and 
then DNA ligase works to ligate the nick.  
 
MMR in eukaryotes is more complex than in prokaryotes and less is known 
about the mechanism. However the main steps of recognition, excision and gap filling 
are conserved across species. In mammals, mismatches are recognised by two MutS 
homologs. Unlike the prokaryotic MutS homodimer (Bjornson et al., 2003) eukaryotic 
homologs of MutS form a heterodimer of two distinct proteins allowing for different 
substrate specificities depending on the subunit protein. MSH2-MSH6 (MutSa) 
heterodimer recognises base to base mismatches and IDLs up to three nucleotides long. 
MSH2-MSH3 (MutSb) recognises IDLs up to 16 nucleotideslong. (Liu, Keijzers and 
Rasmussen, 2017., McCulloch, Gu and Li, 2002). There is no MutH homolog in 
eukaryotes, but the MutL homolog MLH1/PMS2 heterodimer has latent endonuclease 
activity which is thought to carry out the incision of the daughter strand (Kadyrov et al., 
2006). After incision MSH2 and MLH1 recruit exonuclease 1 which excises the 
daughter strand, DNA is re-synthesised by DNA polymerase d (Pol d), and DNA ligase 




Fifteen genes involved in human MMR were identified and used to search for 
within T. vaginalis and T. foetus. The results are shown in Table 4.2. Note that some of 
the homologs, particularly those involved in DNA replication, had previously been 
identified in Table 3.1 due to their involvement in BER as well. BLAST searches with 
all six MutS homologs in T. vaginalis produced the same hits: XP_001322723.1, 
XP_001301506.1, XP_001317815 and XP_001306678. Except for MSH3 and MSH4 
which did not include XP_001306678. Due to this ambiguity, results from the reciprocal 
BLAST searches using the T. vaginalis proteins as queries against the H. sapiens 
database were used in the construction of the results table (Table 3.2).  The same hits 
were also listed in searches with the MutS homologs in T. foetus: OHT00741.1, 
OHT07430.1, OHT11453.1, OHS97192.1. Once again, results from reciprocal BLAST 
searches using T. foetus proteins as queries against the H. sapiens database were 
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Table 3.2: Genes Involved in Mismatch Repair in Humans and their Homologs in T. 
vaginalis and T. foetus. Gene designations and protein names of common proteins involved in 
MMR are listed with the accession numbers for the corresponding human nucleotide sequences. 
BLAST search was used to identify homologs within T. vaginalis (taxid:412133) and T. foetus 
(taxid:1144522). * The accession number for MLH2 from S. cerevisiae (NP_013135) was used as 




3.2.3. Non-homologous End Joining 
 
Non-homologous end joining (NHEJ) repairs double strand breaks (DSB) in DNA. 
DSBs can be caused by ROS action, ionising radiation (Costes et al., 2010), Type 2 
topoisomerase stalling and chemotherapeutic agents. This DNA repair mechanism 
requires the recognition of DNA ends by the Ku heterodimer, made up of Ku70 and 
Ku80 proteins, which binds to the DSB (Davis and Chen, 2013). After binding, the Ku 
heterodimer recruits the other main enzymes involved in NHEJ to the DNA ends, which 
subsequently repair the DSB. These are: DNA-dependent protein kinase catalytic 
subunit (DNA-PKc) (Uematsu et al., 2007), XLF (Tsai, Kim and Chu, 2007), X-ray 
cross complementing protein 4 (Yano et al., 2007), and DNA ligase IV (Costantini et 
al., 2007). DNA-PKcs bind to Ku80 and the phosphorylation of DNA-PKcs causes a 
conformational change allowing the activation of end processing nucleases, such as 
PNKP, and dissociation of DNA-Pkcs (Gottlieb and Jackson, 1993., (Goodarzi et al., 
2006).  XRCC4-Ligase IV complex and XLF then take part in ligation of the DNA 
strand (Gu et al., 2007).  
 
Fifteen genes identified in human NHEJ were used to search for in T. vaginalis 
and T. foetus (Table 3.3). Both T. vaginalis and T. foetus only carry a single gene 
encoding a protein that participates in human NHEJ: MRE11.  Notably, MRE11 also 
participates in homologous recombination (see next section). The results of the BLAST 
searches are shown in Table 3.3. 
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XRCC5 (Ku80 Pku80 
Yku80) 
X-ray repair cross 




XRCC6 (Ku70, Pku70, 
Yku70) 
X-ray repair cross 
complementing protein 6 
NM_001469  x x 
DNA-PK (XRCC7) 










NM_022487  x x 
XLF (NHEJ1)  
XRCC4-like factor 
NM_024782  x x 
APTX 
Aprataxin 
NM_175073  x x 
APLF/PALF 



















NM_013975  x x 
LIG IV (Lig4p)  
DNA ligase 
NM_002312  x x 
Poll 
DNA polymerase 
NM_001174084 x x 
Pol µ 
DNA polymerase 
NM_013284 x x 
 
Table 3.3: Genes Involved in Non-Homologous End Joining in Humans and their Homologs 
in T. vaginalis and T. foetus. Gene designations and protein names of common proteins involved 
in NHEJ are listed with the accession numbers for the corresponding human nucleotide sequences. 





The BLAST search for DNA dependant protein kinase (NM_006904) in both T. 
vaginalis and T. foetus lists hits with acceptable E values; XP_001317016.1 and 
OHT01329.1 respectively. However, when used in a reciprocal BLAST as the query 
against the H. sapiens database both result in FKBP-rapamycin associated protein as 
the top hit and so were not counted as DNA dependant protein kinase homologs. 
 
 
3.2.4. Homologous Recombination 
 
Homologous recombination (HR) also repairs DSB and interstrand crosslinks and 
stalled replication forks. Unlike NHEJ HR repairs DSBs by using the sister chromatid 
sequence as a template strand for high fidelity repair. Due to the use of sister chromatids 
HR is restricted to S and G2 phases of the cell cycle whereas NHEJ can occur in any 
phase. The first step in HR known as ‘pre-synapsis’ is the processing of the DSB to a 
3’ overhang tail. MRE11-RAD50-NBS1 complex (MRN complex) recognises the 
DSBs which are processed by helicases and nucleases including; CtIP, BLM, EXO1, 
and DNA2 (Sartori et al., 2007., Nimonkar et al., 2011). The exposed 3’ single stranded 
overhangs are coated by replication protein A (RPA) to prevent nuclease digestion and 
secondary structure formation. RPA is then removed by recombination mediators, such 
as BRCA2, which allow Rad51 to bind to ssDNA forming the ‘pre-synaptic filament’ 
Rad51 nucleoprotein filament (Sung et al., 2003).  The second step consists of 
homology search and DNA strand invasion together known as synapsis. Rad51 
nucleoprotein filament catalyses homology search and DNA strand exchange into the 
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sister chromatid, forming a joint molecules known as D-loops. The third HR step is the 
postsynaptic phase where the 3’ end of the invading strand is extended by DNA 
synthesis. RAD54 enables the disassociation of RAD51 to allow DNA synthesis mainly 
by polymerase eta in mammals (McIlwraith et al., 2005).  
39 genes identified within homologous recombination in humans and 4 from S. 
cerevisiae were analysed and searched for within the T. vaginalis and T. foetus 



































































NM_024945  x x 
RMI2  RecQ-mediated 
genome instability 
protein 2 
NM_152308  x x 
Top3a DNA 
topoisomerase 3a 


















RPA1 (p70)  Replication 
protein A 1 




RPA2 (p32)  Replication 
protein A 2 
NM_002946  x x 
RPA3 (p11)  Replication 
protein A 3 
NM_002947  x x 
RAD51 
(Rhp51)  










RAD51 paralog C NM_002876  x x 
RAD51D 
(RAD51L3)  
RAD51 paralog D NM_002878  x x 
XRCC2  X-ray repair cross 
complementing 
protein 2 
NM_005431  x x 
XRCC3  X-ray repair cross 
complementing 
protein 3 






NM_134424  x x 
 81 






NM_012415  XP_001304972.1 
 
x 
BRCA1  Breast cancer type 
1 
NM_007294  x x 
BRCA2 
(FANCD1  
Breast cancer type 
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Deleted in split 
hand/split foot 1 
NM_006304  x x 
MUS81  Methyl 
methanesulfonate 
and UV sensitive 
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endonuclease 1  
NM_152463  x x 
SLX1 
(GIYD1) 
Synthetic lethal X 
1 







Synthetic lethal X 
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PARI (Srs2)  PCNA-associated 
recombination 
inhibitor 














Pola DNA polymerase 
alpha 
NM_002689  XP_001316810.1 x 
Pold DNA polymerase 
delta 





















Table 3.4: Genes Involved in Homologous Recombination in Humans and their Homologs in 
T. vaginalis and T. foetus. Gene designations and protein names of common proteins 
involved in HR are listed with the accession numbers for the corresponding human 
nucleotide sequences. BLAST search was used to identify homologs within T. vaginalis 




Gene designation Saccharomyces cerevisiae  Trichomonas vaginalis Tritrichomonas foetus 
Shu1 YHL006 x x 
Psy3 YKR376C  x x 
Rad55 YDR076W  x x 
Rad57 YDR004W  x x 
 
Table 3.5 Genes Involved in Homologous Recombination in S. cerevisiae and their homologs 
in T. vaginalis and T. foetus. Gene designations and protein names of common proteins 
involved in HR are listed with the accession numbers for the corresponding yeast 
protein sequences. BLAST search was used to identify homologs within T. vaginalis 
(taxid:412133) and T. foetus (taxid:1144522).  
 
 
T. foetus ATP-dependent DNA helicase, RecQ family protein (OHS96980.1) 
came up as a top hit for both Bloom syndrome protein (BLM) (NM_000057) and ATP-
dependent DNA helicase Q5/recombinase (RecQL5) (NM_001003715). To determine 
which gene OHS96980.1 was most similar to, the conserved domains of each protein 
were compared using NCBI CDD. All three proteins have a specific hit for the RecQ 
family domain. A reciprocal BLAST search was used to further analyse the protein 
which showed BLM as the top hit.  OHS96980.1 was listed as BLM homolog and the 
other hits listed in the BLAST search were analysed to determine if there is a RecQL5 
homolog in T. foetus. The other hits with acceptable e values were used in reciprocal 
BLASTs; OHT16234.1, OHS98960.1 and OHT08502.1 which all came up with BLM 
as the top hit so were deemed not RecQ5 homologs. Four more hits with acceptable E 
values were ruled out as possible homologs due to low alignment scores <50.   
 
T. vaginalis DNA repair protein RAD51 homolog (XP_001303202.1) was 
shown as the top hit for both RAD51 (NM_002875) and RAD51B (NM_002877). A 
reciprocal BLAST search was carried out, which revealed XP_001303202.1 to be a 
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RAD51 homolog and it was therefore listed in the table as such. The second hit with an 
acceptable E value for RAD51B was the meiotic recombination protein DMC1/LIM15 
homolog (XP_001303137.1). This protein was further analysed to determine if there is 
a RAD51B homolog within T. vaginalis. This reciprocal BLAST showed DNA meiotic 
recombinase 1 (NM_007068.4) as the top hit: therefore T. vaginalis does not have a 
RAD51B homolog. In T. foetus RAD51B BLAST search shows a protein annotated in 
the database as DNA repair protein RAD51 1 (OHT00703.1) as a result, but reciprocal 
BLAST shows it to be more similar to RAD51A.  
 
When searching for RAD54L homologs within T. vaginalis, a protein annotated 
as Type III restriction enzyme, res subunit family protein (XP_001330700.1) came up 
as a top hit with an acceptable E value but upon further analysis with reciprocal BLAST 
it was found to be more similar to H. sapiens excision repair 6 chromatin remodelling 
factor (ERCC6) (NM_000124.4) and so it was discounted as a possible RAD54L 
homolog.  
 
The GEN1 blast search within T. vaginalis and T. foetus resulted in top hits with 
acceptable E values; XP_001294157.1 and OHS94785.1 respectively. These results 
were ruled out as possible GEN1 homologs due to the results of reciprocal BLASTs 
with the proteins against the H. sapiens database not showing GEN1 as the top hit. 
Instead, XP_001294157.1 and OHS94785.1 were found to be most similar to H. sapiens 
FEN1 (NM_004111.6). 
 
The blast search for Pold in T. foetus showed a top hit with an acceptable E 
value, OHT08034.1, which was ruled out as discussed in Section 3.2.1. The same hit 
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was shown when searching for a Polymerase z homologue for homologous 
recombination in T. foetus. The reciprocal BLAST search using OHT08034.1 as query 
returned Polz as the top hit therefore OHT08034.1 was listed as a Polz homologue.  
 
Four genes involved in homologous recombination in S. cerevisiae were 
included in the analysis of T. vaginalis and T. foetus. Shu1, Psy3, Rad55, and Rad57 
play important roles in yeast homologous recombination and are not present in humans. 
These four genes are also missing from both T. vaginalis and T. foetus (Table 3.5). This 
is consistent with findings from other excavates including; Leishmania infantum (L. 
infantum), Leishmania major (L. major), Trypanosoma brucei (T. brucei) and 
Trypanosoma cruzi (T. cruzi) (Genois et al., 2014).   
 
 
3.3. AAG Type Enzymes Throughout the Kingdom of Life   
 
I wanted to explore the spread of AAG within other organisms, including other parasitic 
protists.  To do this I used NCBI’s BLAST search to search for AAG homologs in 
several species from different kingdoms, including other parasitic members of the 
Excavata. I also searched for the DNA methyltransferases; DNMT1, DNMT3A and 
DNMT3B. DNA methyltransferases are a family of enzymes which catalyse the transfer 
of a methyl group to DNA. The rationale for this is that it has been suggested that AAG 




The results identified six species that possessed all three DNMTs in addition to 
AAG: Homo sapiens, Xenopus laevis, Danio rerio, Nematostella vectenis, Ciona 
intestinalis and Amphimedon queenslandica, all of which belong to the Animalia 
kingdom. There was no otherwise obvious correlation in the conservation of any of the 









Table 3.6: Analysis of Presence of AAG, DNMT1, DNMT3A, DNMT3B in a Range of Eukaryotic Species. The accession numbers for the human nucleotide 
sequence for each enzyme (AAG: NP_002425.2) (DNMT1: NP_001370.1) (DNMT3A: NP_072046.2) (DNMT3B: NP_008823.1) were used in BLAST search against 
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T. vaginalis and the related organism T. foetus are the only members of the Excavata 
that we have found to have one or more homologue of AAG, I was interested in how it 
acquired the gene as its evolutionary relatives do not have a copy. To begin to answer 
this question I did an unrestricted BLAST search with T. vaginalis TvAAG1 
(XP_001311901.1) TvAAG2 (XP_016784459.1) and the T. foetus AAG (OHT07844.1) 
to identify the organismal source for the top five hits for each gene (Table 3.7). In each 
case, the top hits were not derived from eukaryotes but were instead prokaryotic 
homologues. The only exception was for TvAAG1, where the second most similar 
protein in the NCBI database was derived from T. foetus. 
 
TvAAG1 TvAAG2 OHT07844.1 





Macellibacteroides sp. HH-ZS 




Parabacteroides chartae Parabacteroides chartae Dysgonomonas 
capnocytophagoides 




Table 3.7 Top Five Most Similar Proteins Identified by an Unrestricted BLAST Search using 
TvAAG1 and TvAAG2 as a Search Term.  Presented in the order as shown in the BLAST 
significant alignments list. TvAAG1 shows TvAAG2 as the top hit and vice versa but were ruled 
out as the purpose of this table is to identify AAGs in other species. Hits that were present in all  





Analysis of DNA repair pathways within T. vaginalis and T. foetus shows that both 
parasites have a greatly reduced number of DNA repair enzymes compared to humans. 
In comparison to each other the parasites have similar conserved DNA repair enzymes, 
which is to be expected as the two parasites are closely related in evolutionary terms 
(Adl et al., 2012).  
 
In BER the parasites are missing some enzymes and proteins essential to the 
human pathway, XRCC1, DNA polymerase b (Polb) and DNA ligase III (LigIII). 
However, they do have copies of certain DNA glycosylases and other BER components 
such as APE1, FEN1 and PCNA. The parasites have a reduced library of glycosylases 
yet the three that are present, UDG, NTHL1 and MPG recognise the majority of lesions 
repaired by BER. Surprisingly the parasites do not have a copy of an 8oxoG specific 
glycosylase such as OGG1. 8oxoG is one of the major oxidative lesions in mammals so 
it would be expected that T. vaginalis and T. foetus have a way of repairing it. The only 
reported members of the Excavata to possess copies of OGG1 are L. major and T. brucei 
(Genois et al., 2014). T. vaginalis and T. foetus lack LigIII which was previously 
thought of as the main ligase involved in short-patch BER, however studies have since 
shown LigIII is not essential in short patch XRCC mediated BER repair (Simsek et al., 
2011 and Gao et al., 2011) suggesting LigIII can be substituted by another ligase during 
BER. Indeed, LigI has previously been shown to substitute for LigIII/XRCC in vivo 
(Sleeth, Robson and Dianov, 2004) T. vaginalis and T. foetus do possess a copy of LigI 
which likely replaces LigIII. This finding is similar to analysis of DNA repair in the 
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parasitic protist Entamoeba histolytica which lacks LigIII and contains a copy of LigI 
for sealing of DNA during DNA repair (Azuara-Liceaga et al., 2018). S. cerevisiae also 
lacks a LigIII homologue and possesses a LigI homologue CDC9 (Tomkinson, Tappe 
and Friedberg, 1992). LigI is known to participate in the long patch repair pathway of 
BER.  In humans, DNA Pold and DNA Pole are used for synthesis of DNA as an 
alternative to DNA Polb in the long patch repair pathway of BER (Fortini et al., 1998). 
T. vaginalis has a copy of DNA Pold and T. foetus has a copy of DNA Pole suggesting 
BER in the parasites takes place via the long patch repair pathway.  This is supported 
by both parasites having a copy of PCNA and RF-C proteins essential for LP-BER 
(Gary et al., 1999; Levin et al., 2000). It is therefore likely that T. vaginalis and T. foetus 
have a preference for LP BER.  
 
Throughout the DNA repair pathways there is some overlap of proteins involved 
in more than one repair pathway. The majority of these proteins are also involved in 
replication. Almost all of the genes encoding replicative proteins are conserved in T. 
vaginalis and T. foetus. LigI is the main ligase involved in the joining of Okazaki 
fragments during lagging strand synthesis of the lagging DNA strand in replication 
(Okazaki et al., 1968). Studies have shown in LigI null mutants are viable which 
suggests LigIII or LigIV can act as alternate ligases during Okazaki fragment ligation 
(Han et al., 2014) LigI is still considered the primary replicative ligase due to the fact it 
is conserved throughout all mammals (Petrini, Xiao and Weaver, 1995) and this holds 
true in T. vaginalis and T. foetus. In eukaryotes DNA Pola, Pold and Pole are considered 
as the three main replicative polymerases. Whilst there are three different models of the 
roles of polymerases at the replication fork the main consensus is that DNA Pola 
initiates DNA synthesis, DNA Pole continues synthesis of the leading strand whilst Pold 
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synthesises the lagging strand ((Stodola and Burgers, 2016).  Out of the 7 DNA 
polymerases analysed T. vaginalis contains three, Pola, Pold and Polζ, and T. foetus 
contains two, Pole and Pol ζ. This is a drastic reduction compared to other excavates, 
Leishmania major, Leishmania infantum, T. cruzi and T. brucei all possess seven 
polymerases (Genois et al., 2013). T. vaginalis DNA replication likely takes place in 
the same manner as other eukaryotes with respect to DNA Pola initiating replication 
however, as the parasite lacks DNA Pole, DNA Pold may synthesise both the leading 
and lagging DNA strands. Pold has been shown to synthesise both strands in 
Schizosaccharomyces pombe by Miyabe et al. (2015) and by Johnson et al 2015. T. 
foetus only possesses Pole out of the three main replicative polymerases, suggesting 
that it is solely responsible for DNA replication within the parasite. Human and S. 
cerevisiae Pole has been shown to participate in leading strand synthesis (Shinbrot et 
al., 2014) but not lagging strand synthesis which leads to the question of how T. foetus 
would replicate the lagging strand. Other replicative proteins that the parasites possess 
include the PCNA sliding clamp. The flap endonuclease FEN-1 and RF-C.  
 
Mismatch repair works to repair base substitutions and insertion-deletion loops. 
T. vaginalis and T. foetus are missing some proteins and enzymes involved in mismatch 
repair, although they do possess the majority of the components essential to the 
pathway.  In eukaryotes mismatch repair is initiated by recognition of base substitution 
or insertion-deletion mismatches by the MutSa heterodimer or the MutSb heterodimer. 
The two heterodimers differ in their recognition of substrate. Both parasites lack MSH3 
part of the MutSb heterodimer, this suggests that they can only repair insertion-deletion 
mismatches of up to 3 nucleotides long via MutSa as MutSb recognises longer IDLs. 
Other species have been found to lack a MSH3 homologue including, Drosophila 
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(Sekelsky et al. 2000), Caenorhabditis elegans (Marti, Kunz and Fleck, 2002) and 
Encephalitozoon cuniculi (E. cuniculi) (Gill and Fast, 2007). After recognition the 
MLH1/PMS2 heterodimer is thought to carry out the incision of the daughter strand, T. 
vaginalis has copies of MLH1/PMS2 however, T. foetus is lacking a PMS2 homologue. 
It could be the case that PMS1, which T. foetus does have a copy of, replaces the 
function of PMS2, or that the daughter strand is incised by a separate endonuclease.  
MSH2 and MLH1 recruit exonuclease 1 in eukaryotic MMR. Both parasites have copies 
of MSH2, MLH1 and Exo1 which, with DNA Pold (T. vaginalis) and DNA Pole (T. 
foetus), can work to complete the repair of base substitution mismatches or insertion-
deletion loops.   
 
Homologous recombination repair is one of two pathways responsible for 
repairing double strand breaks in humans, the second pathway is non-homologous end 
joining. Out of the 39 HR components analysed T. vaginalis possesses 15 and T. foetus 
possesses 16, which includes two homologs of Rad51. MRE11 and RAD50 make up 
the essential MRN complex which acts as a DSB sensor. In mammals the Nijmegen 
breakage syndrome 1 protein (NHS1), or Xrs2 in yeast, is also part of the MRN 
complex. In humans, mutations in the NHS1 gene result in Nijmegen breakage 
syndrome, a condition which causes microcephaly and cancer predisposition (Carney 
et al., 1998; Antoccia et al., 2006).  T. vaginalis and T. foetus contain copies of MRE11 
and RAD50 but surprisingly do not contain a homologue for the NHS1 protein. This 
finding is similar to analysis of HR in Plasmodium falciprium and Toxoplasma gondii 
which also lack a NHS1/Xrs2 homologue (Fenoy et al., 2016; Badugu et al., 2015). The 
parasites may contain another gene that can take over the role of NHS1 in the MRN 
complex or contain such highly divergent copies that bioinformatic analysis has not 
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identified them. T. vaginalis and T. foetus contain homologs for the main enzymes and 
proteins involved in homologous recombination; Mre11, Rad51 , Rad 50, RPA1, BLM, 
BRCA1, Exo1 and polymerase d or e  (as previously discussed) so most likely use solely 
this pathway to repair DSBs.  
 
In respect to non-homologous end joining both T. vaginalis and T. foetus have 
only one enzyme, the MRE11 homolog, out of the 15 analysed. MRE11 is also involved 
in homologous recombination. It is therefore highly likely that both species are unable 
to repair DSBs by non-homologous end-joining. This is consistent with other studies on 
Excavata. Analysis on the Plasmodium falciparum genome sequence did not find any 
proteins involved in NHEJ, except from MRE11, whilst the main proteins involved in 
HR; MRE11, DMC1, Rad50 and Rad51 were present (Gardner et al., 2002). There is 
also evidence of HR in Giardia intestinalis (Sandoval-Cabrera et al., 2015; Ordoñez-
Quiroz et al., 2018) In Trypanosoma brucei  HR is utilised for Variant Surface Glycogen 
(VSG) antigenic coat switching for the evasion of host immune systems ((Proudfoot 
and McCulloch, 2005; Glover, McCulloch and Horn, 2008) whilst key components of 
NHEJ are missing (Genois et al., 2014).    
 
I analysed the presence of AAG in 37 different species which highlighted T. 
vaginalis and T. foetus to be the only excavates with a copy. The rest of the species with 
AAG homologues belonged to the animalia and fungi kingdoms. These results led me 
to question the origin of AAG in both T. vaginalis and T. foetus. An unrestricted blast 
search using T. vaginalis TvAAG1 and TvAAG2 to identify the five most highly similar 
AAG shows prokaryotic AAGs. Both TvAAG1 and TvAAG2 have a highly similar 
copy in Parabacteroides chartae. This bacterium is a member of the bacteroidetes 
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phylum. Bacteroidetes are highly abundant in the human gut (Eckburg, 2005) and their 
presence in the female urogeneital tract is associated with bacterial vaginosis (Ling et 
al., 2010). Bacterial vaginosis is also associated with an increased risk of T.  vaginalis 
infection (Rathod et al., 2011; Brotman et al., 2012, Balkus et al., 2014). Horizontal 
gene transfer has been documented in T. vaginalis, as described in Section 1.2.6. 
Phylogenomic studies by Alsmark et al. (2013) demonstrate horizontal gene transfer 
between T. vaginalis and some bacteriodetes, it is inferred that 89% of HGT cases are 
from the bacteriodes species. Species of bacteriodes are prevalent in the human gut but 
not the female urogenital tract. An unrestricted BLAST search using the T. foetus AAG 
homologue as identified in Table 3.1 also reveals Parabacteriodes chartae as a top hit. 
It is possible that a gut dwelling ancestor of both T. vaginalis and T. foetus participated 
in horizontal gene transfer with an early ancestor of Parabacteriodes chartae.  There is 
phylogenetic evidence that the AAG homologue in the land plant Arabidopsis thaliana 
is a product of an ancestral HGT event with bacteria (Fang et al., 2017). Therefore, it is 
likely that the original source of the genes encoding the two AAG homologues in T. 




The bioinformatical analysis outlined in this chapter provides a comprehensive 
report of the proteins and enzymes involved in four DNA repair pathways within 
two biologically important parasites, Trichomonas vaginalis and Tritrichomonas 
foetus. The analysis shows that both parasites have similar reduced libraries of DNA 
repair proteins and enzymes when compared to humans and other members of the 
excavata. T. vaginalis and T. foetus possess the proteins and enzymes that would 
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allow them to repair a variety of DNA lesions through base excision repair, 
mismatch repair and homologous recombination but not non-homologous end 
joining, of which only one protein was identified.  I have also reported the presence 
or absence of AAG homologues in 37 different species across the kingdoms of life 
and described HGT as a possible source of the two T. vaginalis homologues 
characterised in Chapter 4. 
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4 
Expression and Characterisation of Recombinant 




4.1 Introduction  
 
In the second half of my project I was to continue work on the previously cloned 
recombinant protein T. vaginalis DNA-3-methyladenine glycosylase known as 
TvAAG1 (Daria Kania, manuscript in preparation) and to clone a possible second T. 
vaginalis DNA-3-methyladenine glycosylase homologue, referred to as TvAAG2 in 
this thesis. Both proteins were to be expressed and characterised by biochemical 
methods to identify their substrate specificities, determine their functionality and to 
identify their catalytic domains via site directed mutagenesis. This section of my project 
will try to understand why T. vaginalis has two AAG homologues and establish whether 





4.2 Purification of TvAAG1 from T. vaginalis  
 
Recombinant TvAAG1 was previously expressed in the laboratory using an expression 
vector derived from pET28a (see appendix 1 for plasmid map) containing the coding 
sequence insert for TvAAG1 between NdeI and XhoI restriction enzyme sites. The 
expression vector was transformed into the E. coli protein expression strain Rosetta 2 
(DE3) pLysS and the protein was expressed using the T7 expression system. The T7 
expression system works with a T7 RNA polymerase, which the Rosetta strain has a 
chromosomal copy of,8 that is under the control of the lac operator, and a T7 promoter 
region contained within the pET28a expression vector to allow transcription of the 
inserted gene upon induction on addition of the allolactose analogue, IPTG. The IPTG 
binds to the lac repressor allowing transcription of the gene by derepression of the T7 
RNA polymerase.  The protein was expressed from a 750 mL culture (LB medium) of 
cells.  
 
Recombinant TvAAG1 could be purified using Ni-NTA affinity column 
chromatography. The pET28a expression vector used to express the recombinant 
protein contains an N-terminal 6xHis tag, which allows high affinity binding to the Ni-
NTA resin on the column. The protein was purified through several fractionation steps 
using an increasing concentration of imidazole, which competes with the 6xHis tag to 
bind with Ni-NTA releasing the bound protein. To prepare the harvested cells for 
purification the bacterial cell pellet was resuspended in ice cold Ni-NTA containing 10 
mM imidazole and sonicated to lyse the cells. The suspension was centrifuged and the 
supernatant (“Lysate”, Figure 4.1) was incubated with the Ni-NTA resin before being 
poured through the column. The first collected fraction is composed of unbound 
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proteins that washed through the column (“Flowthrough”, Figure 4.1). The second 
fraction (‘’Wash 1’’, Figure 4.1) was eluted with 10 mM imidazole, the third fraction 
(‘’Wash 2’’, Figure 4.1) was eluted with 35 mM imidazole and the fourth fraction 
collected was the purified protein (‘’Elute’’, Figure 4.1) eluted using buffer containing 
250 mM imidazole.  
 
The fractions were collected and analysed, including the cell lysate from 
centrifugation, using an SDS-PAGE gel (Figure 4.1) and the eluted fraction was 
dialysed in protein dialysis buffer overnight. After dialysis the protein was centrifuged 
at 13,000 rpm for 10 minutes to remove any precipitate and the protein supernatant was 
collected. The protein was produced in good yield at the right size (23 kDa) and more 
than 90% pure as shown in Figure 4.1.  The concentration was measured using UV-vis 
spectrometry and the overall yield was 1.46 mg, corresponding to 1.95 mg/ml of LB 

































Figure 4.1 SDS-PAGE Analysis of TvAAG1 Ni-NTA Affinity Purification. TvAAG1 was 
expressed in Rosetta 2 BL21(DE3)pLysS cells and purified using Ni-NTA column 
chromatography. The protein marker is Precision Plus Protein™ All Blue from Bio-Rad. See 





















































4.3 TvAAG1 Glycosylase Activity Assays 
 
Glycosylase activity assays were used to determine if the enzymes had activity with 
specific substrates and if so, to assess the amount of activity the enzyme had with each 
substrate. Activity was measured on the amount of substrate converted to product 
during the reaction. If active, the glycosylase will remove the modified base by 
cleaving the glycosidic bond. This leaves behind an AP site, which is labile to 
hydrolysis under alkaline conditions. Therefore, heating the product of the reaction 
with buffer containing NaOH will cut the oligomer (39mer) substrate to produce a 













Figure 4.2 Glycosylase Activity Diagram. If the enzyme shows activity the substrate will be 
converted to product which can be observed in the migration of bands after cleavage with NaOH. 
The shorter 18mer product fragments migrate further than the 39mer substrate on the denaturing 












The purified TvAAG1 protein was analysed using glycosylase activity assays 
with various double stranded or single stranded substrates (Figure 4.3) to try to 
characterise its substrate specificity. The protein was diluted in PDB to the appropriate 
concentrations for the assay. Substrate oligomers were labelled with Cy5 and/or 
TAMRA fluorescent labels for imaging. The substrates were made to a final 
concentration of 50 nM in a master mix. The master mix was added to TvAAG1 at 
varying concentrations to start the reaction. The reaction was left to incubate at 37°C 
for 15 minutes and the reaction was stopped by adding an equal volume of formamide 
buffer containing 10 mM NaOH (FA/NaOH). The samples were incubated at 95°C 
before loading onto an 8 M denaturing urea polyacrylamide gel. The gel was imaged 
using the Cy5 channel on a BioRad GelDoc imaging system.  
 
The first substrate I investigated was deoxyinsoine (dI) opposite 
deoxythymidine (dT) (Substrate 1, Figure 4.3). Deoxyinosine arises through hydrolytic 
deamination of deoxyadenosine (dA) and causes transition mutations if not repaired 
(Yasui et al., 2008). dI across from thymine is a well-established substrate for AAG 
type enzymes (O'Brien and Ellenberger, 2003). Figure 4.4 shows the activity assay for 
TvAAG1 and substrate 1.  A doubling of substrate bands can be seen on the gel due to 
the presence of both double-stranded and single-stranded forms. This is a consequence 
of using small gels that do not run at as high a temperature as larger gels, allowing the 
two strands of the substrate to re-anneal. However, the product can be clearly resolved 
from both the double-stranded and single-stranded forms of the substrate, so I continued 
to use the small gels throughout my project. TvAAG1 shows clear concentration 
dependant activity with substrate 1, as conversion to product decreases as TvAAG1 
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concentration decreases, however the concentration dependence is not linear. At 1 µM 













Figure 4.3 Diagram of Substrates used in Glycosylase Activity Assays. All substrates were 39 
nucleotides long and made up to a final concentration of 50 nM for use in glycosylase assay. 
Substrate 1: Double stranded oligomer containing the modified base deoxyinosine across from 
deoxythymidine. Substrate 2: Double stranded oligomer containing deoxyinosine across from 
deoxycytidine. Substrate 3: Single stranded oligomer containing deoxyinosine. Substrate 4: 
Double stranded oligomer containing 8oxoG across from deoxyadenosine. Substrate 5: Double 
stranded oligomer containing uracil across from deoxyadenosine. A = deoxyadenosine C = 




























Figure 4.4 TvAAG1 Glycosylase Activity Assay with Substrate 1. 
TvAAG1 was diluted in PDB to the appropriate concentrations and added to substrate 1 at a final 
concentration of 50 nM. The final concentration of TvAAG1 in each reaction is indicated above the 
relevant lanes. The reaction was incubated for 15 minutes at 37°C. FA/NaOH was added to stop the 
reaction and samples were heated for 5 minutes at 95°C before loading onto an 8 M Urea PAGE gel 
and run for 1 hour at 200 V. S - substrate P – product. The experiment was repeated three times and 
a representative gel is shown. 
 
The next substrate I investigated was dI across from cytosine (Substrate 2, 
Figure 4.3) TvAAG1 shows some activity at higher concentrations of the enzyme, 100 
nM and 10 nM (Figure 4.5). At 100 nM all of the substrate appears to be cleaved 
however, there is only a weak signal for the product band.  In substrate 2 the dI:dC pair 
forms a Watson-Crick base pair (Martin et al., 1985), where dI fits perfectly within the 

































Figure 4.5 TvAAG1 Glycosylase Activity Assay with Substrate 2. TvAAG1 was diluted in 
PDB to the appropriate concentrations and added to substrate 2 at a final concentration of 50 nM, 
the final concentration of TvAAG1 in each reaction is indicated above the relevant lanes. The 
reaction was incubated for 15 minutes at 37°C. FA/NaOH was added to stop the reaction and 
samples were heated for 5 minutes at 95°C before loading onto an 8 M Urea PAGE gel and run for 
1 hour at 200 V. S - substrate P – product. The experiment was repeated two times and a 
representative gel is shown. 
 
Following the results of TvAAG1 with substrate 2, I wanted to investigate the 
activity with a single stranded dI substrate (substrate 3, Figure 4.3). TvAAG1 showed 
minimal activity with substrate 3, less activity than with substrate 1 and 2 as the only 
activity seen is at 100 nM TvAAG1 where not all of the substrate was converted to 































Figure 4.6 TvAAG1 Glycosylase Activity Assay with Substrate 3. TvAAG1 was diluted in 
PDB to the appropriate concentrations and added to substrate 3 at a final concentration of 50 nM, 
the final concentration of TvAAG1 in each reaction is indicated above the relevant lanes. The 
reaction was incubated for 15 minutes at 37°C. FA/NaOH was added to stop the reaction and 
samples were heated for 5 minutes at 95°C before loading onto an 8 M Urea PAGE gel and run for 
1 hour at 200 V. S - substrate P – product. The experiment was repeated two times and a 
representative gel is shown. 
 
Bioinformatic analysis (Chapter 3) indicates that T. vaginalis lacks a 
glycosylase for removal of 8-oxoguanine. This is a surprising observation because 
8oxoG is a frequently occurring modified base (Cheng et al., 1992). I therefore decided 
to investigate whether TvAAG1 acts to remove 8oxoG using a double stranded 
oligomer containing 8oxoG across from (Substrate 4, Figure 4.3).  TvAAG1 did not 
show any activity with substrate 4 at the concentrations tested (Figure 4.7). 
Human AAG has been reported to have some uracil DNA glycosylase activity (Lee et 
al., 2009) therefore I tested TvAAG1 activity with a substrate containing uracil 
(Substrate 5, Figure 4.3) TvAAG1 shows no activity with substrate 5 at the 




























Figure 4.7 TvAAG1 Glycosylase Activity Assay with Substrate 4. TvAAG1 was diluted in PDB 
to the appropriate concentrations and added to substrate 4 at a final concentration of 50 nM, the final 
concentration of TvAAG1 in each reaction is indicated above the relevant lanes. The reaction was 
incubated for 15 minutes at 37°C. FA/NaOH was added to stop the reaction and samples were heated 
for 5 minutes at 95°C before loading onto an 8 M Urea PAGE gel and run for 1 hour at 200 V. S - 
















































Figure 4.8 TvAAG1 Glycosylase Activity Assay with Substrate 5. TvAAG1 was diluted in PDB 
to the appropriate concentrations and added to substrate 5 at a final concentration of 50 nM, the final 
concentration of tvAAG1 in each reaction is indicated above the relevant lanes. The reaction was 
incubated for 15 minutes at 37°C. FA/NaOH was added to stop the reaction and samples were heated 
for 5 minutes at 95°C before loading onto an 8 M Urea PAGE gel and run for 1 hour at 200 V. S - 







































4.4 Schiff Base Assay with TvAAG1 
 
Human AAG is a monofunctional glycosylase and uses an activated water molecule as 
the attacking nucleophile (Lau et al., 1998). However, preliminary data in our laboratory 
(Daria Kania, personal communication) suggested that TvAAG1 might have an 
alternative mechanism and uses a lysine as the attacking nucleophile, with associated 
AP lyase activity (i.e. it may be a bifunctional enzyme). To determine whether TvAAG1 
is indeed bifunctional, I carried out a Schiff base assay. 
 
The Schiff base assay works on the principle of trapping a covalent intermediate 
that can be identified using SDS-PAGE. The intermediate is only formed if the 
glycosylase is bifunctional and has b-lyase activity. Borohydride reduction of the Schiff 
base results in formation of a covalent DNA-glycosylase intermediate which can be 
trapped and visualised on the gel.  
 
TvAAG1 was incubated with substrate 1 (figure 4.3) in the presence or absence 
of 2.5 mM cyanoborohydride (CB) for 15 minutes at 37°C and loaded onto the SDS 
PAGE gel after heating at 95°C for 5 minutes (Figure 4.9). Human NTH1 (hNTH1), a 
known bifunctional glycosylase, was used as the control lane without CB (lane 1, Figure 
4.9) and with CB (lane 2, Figure 4.9). The enzyme hNTH1 was previously purified in 
the lab. As expected, there are no bands in the TvAAG1 without CB lane (lane 3, Figure 
4.9) or the no protein control lane (lane 5, Figure 4.9). There are two bands in the 
TvAAG1 with CB lane (lane 4, Figure 4.9) which suggests TvAAG1 forms an 






















Figure 4.9 Schiff Base Assay with TvAAG1 and Cyanoborohydride. TvAAG1 and the control 
enzyme hNTH1 were incubated with or without cyanoborohydride (CB) at a final concentration of 
2.5 mM in addition to master mix for 15 minutes at 37°C. Samples were stained with SDS loading 
buffer preheated for 5 minutes at 95°C and loaded alongside Precision Plus Protein™ All Blue (Bio-
Rad). The gel was ran for 45 minutes at 220 V with 1 X TGS buffer and visualised with Chemidoc 
XRS+ Fluro orange setting. M) Marker. 1) NTH1. 2) NTH1 + CB. 3) TvAAG1. 4) TvAAG1 + CB. 

















A second Schiff base assay was conducted to test the bifunctional activity of 
TvAAG1 on an abasic site. An abasic site was generated in-situ by the monofunctional 
enzyme uracil-DNA glycosylase which acts on uracil and leaves an AP site. In theory 
the AP site could be acted upon by a bifunctional glycosylase. When TvAAG1 is added 
to the in-situ generated AP site (lane 4, Figure 4.10) there are three clear bands produced 
suggesting formation of the covalent intermediate formed through bifunctional 
glycosylase activity and borohydride trapping. As expected, there are no bands in the 
uracil only or TvAAG1 and uracil lanes (lanes 1 and 3, Figure 4.10). Two bands can be 
seen in the uracil and UDG lane (lane 2 Figure 4.10). UDG is a monofunctional 
glycosylase so the formation of a band is unexpected. Human UDG used in the Schiff 
base assay was sourced from Sigma Aldrich. The production of the covalent 
intermediates is possibly due to contamination of the commercial UDG used by other 































Figure 4.10 Schiff Base Assay with TvAAG1 and an in situ Generated Abasic Site. TvAAG1 
and the control enzyme UDG were incubated with or without cyanoborohydride (CB) at a final 
concentration of 2.5 mM in addition to master mix for 15 minutes at 37°C. Samples were stained 
with SDS loading buffer preheated for 5 minutes at 95°C and loaded alongside Precision Plus 
Protein™ All Blue (Bio-Rad). The gel was ran for 45 minutes at 220 V with 1 X TGS buffer and 
visualised with Chemidoc XRS+ Fluro orange setting. M) Marker 1) Uracil. 2) Uracil + UDG. 3) 
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4.5 Molecular Cloning and Expression of TvAAG2 
 
The second enzyme I investigated in my project is a possible second T. vaginalis AAG 
homologue identified during bioinformatic analysis (Chapter 3) and known throughout 
this thesis as TvAAG2. My aim was to successfully clone and try to determine the 
substrate specificity for this enzyme. 
 
A cloning vector containing the DNA sequence coding for TvAAG2 flanked by 
NdeI and XhoI restriction sites was obtained from the Invitrogen gene synthesis service. 
The expression vector pET-28a was obtained from Novagen. The TvAAG2 insert was 
cloned into the pET28-a vector (Figure 4.11) using NdeI and XhoI restriction enzymes. 
Success of the restriction reaction to produce the insert was identified via agarose gel 
electrophoresis. The band was cut out of the agarose gel and purified with a gel 
extraction kit. The insert was then ligated to pET28a cut with the same restriction 
enzymes.  The ligation products were used to transform NEB Turbo E. coli competent 
cells, which were plated on kanamycin selection agar. Several colonies were obtained 
after overnight incubation. LB broth was inoculated with single colonies and these 
cultures were grown overnight. The cells were harvested and the plasmids from each 
clone isolated using Gene JET Plasmid Miniprep kit (Fisher). Plasmids were screened 
for the presence of insert by digestion with NdeI/XhoI (see Figure 4.12). Two of the 
clones contained insert of approximately the right size (lanes 2 and 3, Figure 4.12). The 
plasmid was then sent off for sequencing to confirm successful cloning of TvAAG2.   
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Protein was expressed from this vector in RosettaTM BL21(DE3)pLyyS cells 
using the T7 expression system. The Rosetta strain has a chromosomal copy of T7 RNA 
polymerase, and the pET28-a expression vector used to construct the plasmid contains 
a T7 promoter region and lacI coding sequence upstream of the insert allowing the 
transcription of the gene by the T7 RNA polymerase upon IPTG induction. Rosetta cells 
were transformed with the plasmids and plated on LB agar plates with 
kanamycin/chloramphenicol antibiotics. Single colonies were used to inoculate 5 ml LB 
broth cultures, containing kanamycin and chloramphenicol at the appropriate 
concentration, which was incubated overnight and used to inoculate 750 ml LB broth 
cultures containing kanamycin and chloramphenicol. The cells were left to grow to mid-
log phase (0.6 OD). Up until this point cells were replicating but TvAAG2 was not 
transcribed, as the T7 promoter region on the pET28a plasmid was repressed by the lac 
repressor, coded for by the lacI gene, which binds to the lac operon upstream of the T7 
RNA Polymerase gene (see Section 4.2 for more detailed explanation).  After passing 
mid-log phase isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to the cultures 
to a final concentration of 1 mM to induce protein expression. IPTG is a molecular 
mimic of allolactose which can bind to the lac repressor causing a conformational 
change and dissociation from the operon allowing T7 RNA polymerase to transcribe 
the TvAAG2 sequence. The cultures were left to incubate for a further three hours after 
IPTG induction to allow for accumulation of TvAAG2. The cells were harvested using 


























Figure 4.11 Simplified Map of pET28a+ Expression Vector  
The pET28a vector was obtained from Novagen and used with NdeI and XhoI restriction enzymes 


































Figure 4.12 Restriction Digests of Plasmids Isolated from Clones Obtained from Ligation of 
TvAAG2 Coding Sequence into pET28a Vector.  Agarose gel electrophoresis loaded with 100 
bp DNA ladder (NEB) (lane 1) and restriction digests (lane 1-4) ran for 1 hour at 90 V. The band 
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4.6 Purification of TvAAG2 
TvAAG2 was expressed in RosettaTM BL21(DE3)pLysS and successfully purified 
using the same Ni-NTA purification method as described in Section 4.2. Figure 4.13 
shows the purification of TvAAG2 and shows the protein was successfully produced at 


















Figure 4.13 SDS-PAGE of TvAAG2 Ni-NTA Affinity Purification. TvAAG2 was expressed in 
Rosetta BL21(DE3)pLysS cells and purified using Ni-NTA column chromatography. The protein 
marker is Precision Plus Protein™ All Blue from Bio-Rad. The elute fraction was frozen at -80°C 
















































4.7 TvAAG2 Glycosylase Activity Assays 
 
TvAAG2 was subjected to the same glycosylase activity assays with the same 
conditions described in Section 4.3 with the substrates described in Figure 4.3. The first 
substrates tested were the ones containing deoxyinosine; substrate 1, substrate 2 and 
substrate 3.  TvAAG2 shows some activity with substrate 1 (Figure 4.14, A) and 
minimal activity with substrate 2 and 3 (Figure 4.14, B and C respectively). In all three 
cases TvAAG2 had far less activity compared with TvAAG1 activity on the same 
substrates suggesting that, although TvAAG2 does recognise dI as a lesion, dI may not 
be its primary substrate due to the limited activity seen with the activity assays. The 
second set of substrates tested with TvAAG2 were uracil and 8oxoG. TvAAG2, like 
TVAAG1, had no activity with substrate 4 or substrate 5 at the concentrations tested 





































Figure 4.14 Glycosylase Activity Assays for TvAAG2 with Substrates 1-3.  TvAAG2 was 
diluted in PDB to the appropriate concentrations and added to substrate 3 at a final concentration 
of 50 nM, the final concentration of TvAAG2 in each reaction is indicated above the relevant 
lanes. The reaction was incubated for 15 minutes at 37°C. FA/NaOH was added to stop the 
reaction and samples were heated for 5 minutes at 95°C before loading onto an 8 M Urea PAGE 
gel and run for 1 hour at 200 V. S – substrate P – product. A) substrate 1. B) substrate 2. C) 





















































































Figure 4.15 Glycosylase Activity Assays for TvAAG2 Substrate 4 and 5. TvAAG2 was diluted 
in PDB to the appropriate concentrations and added to substrate 5 at a final concentration of 50 
nM, the final concentration of TvAAG2 in each reaction is indicated above the relevant lanes. The 
reaction was incubated for 15 minutes at 37°C. FA/NaOH was added to stop the reaction and 
samples were heated for 5 minutes at 95°C before loading onto an 8 M Urea PAGE gel and run for 
1 hour at 200 V. S – substrate P – product. A) substrate 4. B) substrate 5. The experiment was 

















































4.8 Schiff Base Assay with TvAAG2 
 
TvAAG2 was used in the same Schiff base assay as described in Section 4.4. Figure 
4.16 shows the Schiff base assay with NTH1 and TvAAG2. NTH1 without and with 
CB are the control lanes (lanes 1 and 2 respectively, Figure 4.16). As expected, there is 
no band in lane 1 and one band in lane 2. There is one band in the TvAAG2 without CB 
(lane 3, Figure 4.16) and two bands in the TvAAG2 plus CB (lane 4, Figure 4.16). These 
bands are possibly due to some intrinsic fluorescent component in the TvAAG2, as they 



































Figure 4.16 Schiff Base Assay with TvAAG2. TvAAG2 and the control enzyme NTH1 were 
incubated for 15 minutes at 37°C with 1 µl of 50 nM cyanoborohydride (CB) in addition to master 
mix. Samples were stained with SDS loading buffer preheated for 5 minutes at 95°C and loaded 
alongside Precision Plus Protein™ All Blue (Bio-Rad). The gel was ran for 45 minutes at 220 V 
with 1 X TGS buffer and visualised with Chemidoc XRS+ Fluro orange setting. 1) NTH1. 2) 
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4.9 Identification of Conserved Residues for Site Directed Mutagenesis Targets 
 
To identify possible catalytic domains of TvAAG1 and TvAAG2, the NCBI accession 
numbers for each gene (XP_001311901.1 and XP_001315594.1 respectively) were 
used in NCBI protein BLAST search to find closely related species with homologues 
of the gene. Species close to the top of the list for TvAAG1and TvAAG2 were chosen 
for an alignment with CLUSTAL Omega (Table 4.1). This alignment was used to 
identify conserved lysine residues, as bifunctional glycosylases require an active site 
lysine (Jacobs and Schär, 2011). Only one uniquely conserved lysine was found and is 
highlighted in the alignment in Figure 4.17. This lysine was the target for site directed 
mutagenesis for both genes.     
 
 
Table 4.1 Species Chosen for Clustal Omega Alignment. Species names and their NCBI 
accession numbers for the species chosen to be used in an alignment with T. vaginalis 








Species NCBI accession number  
Draconibacterium sediminis WP_045025985.1 
Draconibacterium orientale  SES79290.1 
Parabacteroides chartae WP_079683634.1 
Tritrichomonas foetus  OHT07844.1 
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Figure 4.17 Multiple Sequence Alignment of Trichomonas vaginalis TvAAG1 and TvAAG2 
with Closely Related Species with 3-methyladenine DNA Glycosylases. Species were found 
with a BLAST search of T. vaginalis TvAAG1 and TvAAG2. The FASTA sequences of the genes 
were collected from NCBI and pasted into Clustal Omega. The output from Clustal Omega was 
copied and used with BoxShade to colour conserved (black) and similar (grey) residues. This 
alignment was used to identify conserved lysines to be targeted in site directed mutagenesis. The 












4.10 Site Directed Mutagenesis and Purification of TvAAG1 and TvAAG2 
Mutants 
 
Primers for site directed mutagenesis (SDM) were designed using the Quikchange 
Primer Design Program at Agilent genomics website.  Primers were designed for two-
point mutations at lysine 124 of TvAAG1: lysine to alanine (known as K124A mutant), 
which should abolish activity and lysine to arginine (K124R mutant) which should 
partially reduce the activity (Liu and Roy, 2001). Primers were designed for the same 
point mutations at lysine 123 of TvAAG2: lysine to alanine (K123A mutant) and lysine 
to arginine (K123R mutant). SDM was carried out using Phusion Flash DNA 
polymerase within a thermal cycler (Figure 4.18). After incubation with DpnI to digest 
the wild-type template plasmid, the SDM mixture was used to transform Turbo E. coli 
competent cells. Plasmids were isolated from individual clones and sent for sequencing 





























Figure 4.18: Quik Change Site Directed Mutagenesis. 1) Thermal cycling denatures the DNA 
template, anneals the mutagenic primers and primers are extended with Phusion Flash DNA 
polymerase. 2) Parental DNA is digested with DpnI. After digestion the SDM mixture is 
transformed into E. coli competent cells. 
 
After successful identification of mutated plasmids, Rosetta™ 2 DE3 pLysS 
cells were transformed with these plasmids and the mutant proteins purified as 
previously described (Section 4.2) Samples for SDS PAGE gels were taken during 
purification for each mutant protein; the supernatant ‘’Lysate’’, the unbound proteins 
washed through the column ‘’Flowthrough’’, the first elution ‘’Wash 1’’, the second 

















mutants were unsuccessful, with very low yields. Eventually, successful purifications 
of each mutant were carried out. Figure 4.19 – 4.22 show the SDS PAGE gels of the 
mutant protein purifications. The overall yield for the mutant proteins were; 0.11 mg 
(K124A, Figure 4.19), 0.4 mg (K124R Figure 4.20), 0.16 mg (K123A Figure 4.21), 









































Figure 4.19: SDS-PAGE Gel of Purification Fractions Collected from Ni-NTA Affinity 
Column from TvAAG1 K124A Mutant Proteins. TvAAG1 K124A was expressed in Rosetta 2 
BL21(DE3)pLysS cells and purified using Ni-NTA column chromatography. The protein marker 




























































Figure 4.20: SDS-PAGE Gel of Purification Fractions Collected from Ni-NTA Affinity 
Column from TvAAG1 K124R Mutant Proteins. TvAAG1 K124R was expressed in Rosetta 2 
BL21(DE3)pLysS cells and purified using Ni-NTA column chromatography. The protein marker 
































































Figure 4.21: SDS-PAGE Gel of Purification Fractions Collected from Ni-NTA Affinity 
Column from TvAAG2 K123A Mutant Proteins. TvAAG2 K123A was expressed in Rosetta 2 
BL21(DE3)pLysS cells and purified using Ni-NTA column chromatography. The protein marker 


































































Figure 4.22: SDS-PAGE Gel of Purification Fractions Collected from Ni-NTA Affinity 
Column from TvAAG2 K123R Mutant Proteins. TvAAG2 K123R was expressed in Rosetta 2 
BL21(DE3)pLysS cells and purified using Ni-NTA column chromatography. The protein marker 























































4.11 TvAAG1 and TvAAG2 Mutant Glycosylase Activity Assays  
 
Glycosylase activity assays were carried out with TvAAG1 K124A, K124R and TvAAG2 
K124A and K24R mutants as described in Section 4.3 with the substrates described in Figure 
4.3. Wildtype TvAAG1 or TvAAG2 at 100 nM and 1 pM were used as control lanes.  
The K124A mutation abolished TvAAG1 activity as seen in Figure 4.23 the K124A mutant had 
no activity with substrate 1 or substrate 2 at the concentrations tested (A and B respectively). 
The K124R mutation reduced activity with substrate 1, at 100 nM K124R not all of the substrate 
was converted to product compared to the100 nM wild type control lane in which all the 
substrate was converted to product (Figure 4.24, A). K124R also reduced activity with substrate 
2 (Figure 4.24, B) which again can be seen in the reduction of activity in the 100 nM K124R 
lane compared to 100 nM TvAAG1 control. The next experiment I carried out was to assess the 
extent of the reduction in activity by K124R by using a wider range of enzyme concentrations 
with substrate 1. The wildtype TvAAG1 control shows clear activity on substrate 1 from 100 
nM to 6.25 nM, whereas activity at 50 nM K124R is far less. Activity on substrate 1 then 
































Figure 4.23: Glycosylase Activity Assay TvAAG1 K124A Substrate 1 and 2.  TvAAG1 was 
diluted in PDB to the appropriate concentrations and added to substrate 2 at a final concentration 
of 50 nM, the final concentration of tvAAG1 in each reaction is indicated above the relevant lanes. 
The reaction was incubated for 15 minutes at 37°C. FA/NaOH was added to stop the reaction and 
samples were heated for 5 minutes at 95°C before loading onto an 8 M Urea PAGE gel and run for 
1 hour at 200 V. S - substrate P – product. A) Substrate 1. B) Substrate 2. The experiment was 






















































































Figure 4.24: Glycosylase Activity Assays for TvAAG1 K124R Substrate 1 and 2. TvAAG1 
was diluted in PDB to the appropriate concentrations and added to substrate 2 at a final 
concentration of 50 nM, the final concentration of tvAAG1 in each reaction is indicated above the 
relevant lanes. The reaction was incubated for 15 minutes at 37°C. FA/NaOH was added to stop 
the reaction and samples were heated for 5 minutes at 95°C before loading onto an 8 M Urea 
PAGE gel and run for 1 hour at 200 V. S - substrate P – product. A) Substrate 1. B) Substrate 2. 



















































































Figure 4.25: Glycosylase Activity Assay TvAAG1 and TvAAG1 K124R with dIdT Substrate 
at Concentrations between 100 nM and 10 nM.  TvAAG1 was diluted in PDB to the appropriate 
concentrations and added to substrate 1 at a final concentration of 50 nM, the final concentration 
of TvAAG1 in each reaction is indicated above the relevant lanes. The reaction was incubated for 
15 minutes at 37°C. FA/NaOH was added to stop the reaction and samples were heated for 5 
minutes at 95°C before loading onto an 8 M Urea PAGE gel and run for 1 hour at 200 V. S - 
substrate P – product. The experiment was repeated two times and a representative gel is shown. 
 
Glycosylase activity assays for TvAAG2 mutants were carried out using 
substrate 1 and 2, despite TvAAG2 only showing minimal activity with these substrates, 
as a suitable substrate which was not identified during Section 4.7. K123A abolished 
the minimal activity seen at 100 nM TvAAG2 with substrate 1 (Figure 4.26, A) as 
expected. K123R slightly reduced the minimal activity seen at 100 nM TvAAG2 in 
Figure 4.27, A. The control lanes with TvAAG2 and substrate 2 (Figure 4.26 B, Figure 
4.27 B) showed no activity therefore the effects of K123A and K123R activity on 
substrate 2 could not be determined.  
 
 






































































Figure 4.26: Glycosylase Activity Assays for TvAAG2 K123A with Substrate 1 and 2. TvAAG2 
was diluted in PDB to the appropriate concentrations and added to substrate 2 at a final concentration 
of 50 nM, the final concentration of TvAAG1 in each reaction is indicated above the relevant lanes. 
The reaction was incubated for 15 minutes at 37°C. FA/NaOH was added to stop the reaction and 
samples were heated for 5 minutes at 95°C before loading onto an 8 M Urea PAGE gel and run for 
1 hour at 200 V. S - substrate P – product. A) Substrate 1. B) Substrate 2. The experiment was 
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Figure 4.27: Glycosylase Activity Assays for TvAAG2 K123R Substrate 2. TvAAG2 was 
diluted in PDB to the appropriate concentrations and added to substrate 2 at a final concentration 
of 50 nM, the final concentration of tvAAG1 in each reaction is indicated above the relevant lanes. 
The reaction was incubated for 15 minutes at 37°C. FA/NaOH was added to stop the reaction and 
samples were heated for 5 minutes at 95°C before loading onto an 8 M Urea PAGE gel and run for 
1 hour at 200 V. S - substrate P – product. The experiment was repeated three times and a 
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In my project I have successfully demonstrated that TvAAG1 is a bifunctional 
glycosylase by the use of Schiff base assays. TvAAG1 is the first bifunctional AAG 
type enzyme to be identified, as there are currently non-described within the literature. 
The human AAG enzyme MPG is monofunctional as evidenced by the activated water 
molecule in its active site (Lau et al., 1998). E. coli has two AAG type enzymes TAG 
and AlkA which are both monofunctional (Thomas, Yang and Goldthwait, 1982; 
Nakabeppu et al 1984). As are the AAG type enzymes in; Bacillus subtilis (Aamodt et 
al., 2004) Saccharomyces cerevisiae (Chen, Derfler and Samson, 1990) Helicobacter 
pylori (O'Rourke et al., 2000) and Thermotoga maritima (Begley et al., 1999).  
I have also characterised TvAAG1 substrate specificity with the use of glycosylase 
activity assays. TvAAG1 has activity with deoxyinosine in a double stranded oligomer 
across from deoxythymidine and across from deoxycytidine. The glycosylase has 
significantly more activity with dI:dT than dI:dC, this preference is consistent with 
other studies within the literature (Wyatt and Samson, 2000; Connor and Wyatt, 2002). 
Deoxyinosine is structurally similar to deoxyguanine and as such forms a Watson-Crick 
base pair with deoxycytidine making it harder for TvAAG1 to recognise dI within the 
DNA backbone (Figure 4.28). O'Brien and Ellenberger (2003) show that a normal G:C 
Watson-Crick base pair is 50-fold more resistant to human AAG compared to a G:T 
mismatch. They suggest a way of ensuring unmodified bases are not excised by AAG 
is to discriminate against Watson-Crick base pairs making them less likely to be flipped 
into the active site. Even though TvAAG1 can recognise dI as a substrate, its structure 
when in a base pair with dC reduces TvAAG1 ability to flip it into the active site for 
catalysis and therefore reduces rate of excision.  TvAAG1 has minimal activity with 
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single stranded deoxyinosine substrate and, unlike human AAG, does not have activity 
with uracil containing substrates. 
In the bioinformatics section of this project (Chapter 3) I discovered that T. vaginalis 
lacks an 8oxoG specific glycosylase, some AAGs have been shown to act on 8oxoG 
lesions lesions (Bessho et al., 1993 and Wyatt and Samson 2000). However, no activity 
was seen with the 8oxoG substrate. It can be assumed that TvAAG1 and TvAAG2 do 
not compensate for the lack of OGG1 or similar enzyme. 
 
 
Figure 4.28: Deoxyinosine Paired with Deoxycytidine and Deoxythymidine. Deoxyinosine (I) 
paired to deoxycytidine (C) forms a Watson-Crick base pair whilst deoxyinosine paired with 
deoxythymidine (T) forms a less stable pair.  
 
In regard to TvAAG2 I have not been able to identify a substrate that the enzyme 
is significantly active with. TvAAG2 has very small, minimal activity on both dI:dT 
and dI:dC and the single stranded dI substrate. TvAAG2, like TvAAG1, has no activity 
with 8oxoG or uracil substrates. Other AAG type enzymes are known to be active with 
highly mutagenic etheno adducts produced from lipid peroxidation and environmental 
pollutants. Human AAG, S. cerevisiae MAG and E. coli AlkA enzymes can recognise 
and cleave the etheno adduct 1,N6-ethenoadenine (Saparbaev, Kleibl and Laval, 1995; 
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Hang et al., 1997; Lingaraju et al., 2008 ). TvAAG2 may be specific for this type of 
damage within T. vaginalis. 
 
The site-directed mutagenesis I carried out successfully identified the critical 
lysine residue present in both TvAAG1 and TvAAG2 active sites, strongly supporting 
our hypothesis that the enzyme is bifunctional, in contrast to previously characterised 
AAGs. The lysine – arginine mutations reduced TvAAG1 activity whilst lysine – 
alanine mutations completely abolished activity. TvAAG2 mutations did not show 
much of a reduction of activity as the optimal substrate for TvAAG2 was not identified 
for use in the mutant assays. 
 
 
4.13 Conclusion  
 
The work detailed in this chapter identifies that dI:dT is the optimal substrate for an 
alkyladenine glycosylase homologue from Trichomonas vaginalis, and also provides 
strong evidence that it has a bifunctional reaction mechanism. To our knowledge, this 
is the first such bifunctional AAG homologue to be characterised. I have also expressed 
and carried out the first preliminary characterisation of the activity of a second AAG 
homologue present in T. vaginalis. Further studies should be carried out to characterise 
TvAAG2 substrate specificity, in particular studies using eA substrates. As a substrate 
was not found it cannot be said if TvAAG2 is truly a TvAAG1 homologue, but the 






DNA repair pathways have evolved to protect and ensure the faithful replication 
of DNA against damage arising from endogenous and exogenous sources. The 
significance of DNA repair is evidenced by the fact that it is a mechanism that is 
conserved, in some form, throughout all life.  Trichomonas vaginalis is the causative 
agent of the most prevalent, non-viral, sexually transmitted infection worldwide (WHO, 
2012). The published draft genome of T. vaginalis has enabled further research to be 
undertaken on this once elusive parasite (Carlton et al., 2007). As a member of the 
excavata (Adl et al., 2012), an early diverging group of eukaryotes, insights from T. 
vaginalis DNA repair pathways may begin to explain the evolution of DNA repair in 
other eukaryotes.  
 
The two enzymes described in this research are DNA 3-methyladenine 
homologues. Bioinformatical analysis of a wide range of eukaryotes reveals almost no 
other eukaryotes, except from T. vaginalis, T. foetus and some animal species, to 
possess an AAG homologue. This raises the question of how and why these two 
parasites have a base excision repair glycosylase when it is not conserved in any of their 
evolutionary relatives, Leishmania, Trypanosoma or indeed the majority of other 
eukaryotes. Horizontal gene transfer is documented in other parasites as a source of 
novel genes which can allow the evolution of pathogenic traits (Alsmark et al., 2013; 
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Trasviña-Arenas et al., 2019). As discussed in 3.4 the likely source of TvAAG1 and 
TvAAG2 is through horizontal gene transfer between an ancient ancestor of both T. 
vaginalis and T. foetus and a prokaryote related to the bacteroidetes lineage. The AAG 
type homologue in Arabidopsis thaliana is also product of horizontal gene transfer 
(Fang et al., 2017). It is unknown if the parasites utilize the AAG glycosylases for 
survival or if, as knockout studies in mice show the enzyme does not contribute to 
lethality (Engelward et al., 1997), the genes are redundant. Some eukaryotes have a 
wide range of DNA glycosylases with overlapping substrate specificities which may 
explain how other eukaryotes can repair deamination and oxidation damage without 
AAG.  
 
Another major question identified by bioinformatic analysis of the BER is the 
repair of the highly mutagenic lesion 8oxoG. Both parasites lack an 8oxoG specific 
enzyme (i.e OGG1) and neither TvAAG1 nor TvAAG2 compensates for the repair of 
this lesion. The lack of an 8oxoG specific enzyme is an unusual finding as 8oxoG is a 
frequently occurring lesion, the parasites may have an alternate mechanism to repair 
this type of DNA damage. This finding is consistent with research on the parasitic 
protist E. histolytica who also lacks OGG1 (López-Camarillo et al., 2009). 
 
Both T. vaginalis and T. foetus lack nearly all of the genes used in the Non-
homologous end joining pathway. The only gene present, MRE11, is also used in 
homologous recombination. This suggests double strand breaks can only be repaired 
via homologous recombination during S and G2 phases of the cell cycle. However, as 
the cell cycle in Trichomonads is not well studied, homologous recombination may not 
be limited as it is in mammalian cells. The lack of genes involved in NHEJ is also 
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consistent with findings in other excavates including Plasmodium falciparum (Gardner 
et al., 2002), T. brucei, T. cruzi, L. infantum and L. major (Genois et al., 2014). 
 
In this project I have successfully demonstrated TvAAG1 as the first 
bifunctional AAG glycosylase, as non are currently described within the literature. 
Additionally, I have defined its optimal substrate, deoxyinosine across from 
deoxythymine, and carried out the first characterisation of TvAAG2 
throughglycosylase activity assays. I have also created a comprehensive atlas of DNA 
repair proteins and enzymes for both T. vaginalis and Tritrichomonas foetus by 
bioinformatical means. The first thorough documentation of these pathways with regard 
to these particular parasites.  
 
This research establishes the foundation for new research on both T. vaginalis 
and T. foetus and their DNA repair pathways. The first report of CRISP/Cas9 gene 
knockout studies in T. vaginalis cells was published last year (Janssen et al., 2018). In 
light of this, future research could use CRISPR/Cas9 knockouts of TvAAG1 and 
TvAAG2 to establish any changes in phenotype caused by the loss of one, or both genes. 
Any lethality or hypersensitivity to DNA damaging agents seen in T. vaginalis cells 
after gene knockouts would allow further characterisation of both TvAAG1 and 
TvAAG2 and the establishment of whether the genes are an evolutionary advantage or  
indeed, redundant. In light of increased reports of antibiotic resistant T. vaginalis strains 
(Schwebke and Barrientes, 2006; Upcroft et al., 2009) research into the origins of its 
DNA repair proteins may be advantageous as homologues of bacterial origin, that differ 
enough from the corresponding human homologues, could be used as novel drug targets 
or for vaccine design.   
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Appendix 1: pET28a+ Map : Image taken from the Novagen pET28a+ vector map accessed at 
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